Dr. (Prof.) Deep Dutta is on the forefront among the new generation of endocrinologist from India, who believe in newer innovations in the practice of Endocrinology with the aim of improving patient care, comfort and satisfaction. He has contributed several important original research papers in the field of THYROID REVERSAL, DIABETES REVERSAL, DIABETES PREVENTION, vitamin-D metabolism and bone health, thyroid function and PREVENTION OF HYPOTHYROIDISM, growth and puberty disorders & SHORT STATURE in children. He is among the first to highlight the burden of prediabetes among young Indians, and the need to take urgent interventions to prevent the diabetes epidemic in India. His work on novel cheap diagnosing tool for localizing parathyroid tumors which cannot be localized through conventional imaging has been recognized internationally

323 indexed publications in high impact international journals of repute. Publications as first author/ corresponding author: 202 H-index: 38; i10-index: 149; Citations: 6503 (As of 24 September 2026) (Source: https://scholar.google.co.in/citations?user=8Upe3CAAAAAJ&hl=en) https://www.ncbi.nlm.nih.gov/myncbi/deep.dutta.1/bibliography/public/

Research Publications

  1. Dutta D, Mahajan K, Mittal A, Jena S, Agarwal K, Kamrul-Hasan ABM. Aromatase inhibitors, GnRH analogs and growth hormone for short stature with advanced bone age in adolescent boys: A Bayesian network meta-analysis. Endocr Pract. 2026 Aug 17:S1530-891X(26)01113-4. doi: 10.1016/j.eprac.2026.08.012. Epub ahead of print. PMID: 42607811.
  2. Dutta D, Mahajan K, Jena S, Kamrul-Hasan ABM, Sharma M, Bhattacharya S. Feto-maternal safety of statins in pregnancy: An updated systematic review and meta-analysis.Diabetes Metab Syndr. 2026 Aug 13;20(8):103472. doi: 10.1016/j.dsx.2026.103472. Epub ahead of print. PMID: 42607353
  3. Dutta D, Mahajan K, Kamrul-Hasan ABM, Mahajan N, Sharma M, Vohra S. Impact of glucagon-like peptide-1 receptor agonism-based therapies on limb outcomes in peripheral artery disease and type 2 diabetes: An updated systematic review and meta-analysis. Diabetes Obes Metab. 2026 Mar;28(3):2075-2084. doi: 10.1111/dom.70391. Epub 2025 Dec 22. PMID: 41424191.
  4. Dutta D, Jena S, Mahajan K, Kamrul-Hasan ABM, Bhattacharya S, Mohindra R. Safety and efficacy of glucagon like peptide-1 receptor agonism-based therapies in end-stage renal disease: A systematic review and meta-analysis. Endocr Pract. 2026 Aug 4:S1530-891X(26)01086-4. doi: 10.1016/j.eprac.2026.07.018.
  5. Mahajan K, Jena S, Dutta D, Kamrul-Hasan ABM, Sharma J, Himral S, Mansk PG, Mahajan N. Efficacy and Safety of Upfront Oral Triple Lipid-Lowering Therapy: A Systematic Review and Single-Arm Meta-Analysis. Diabetes Obes Metab. 2026 Mar 16. doi: 10.1111/dom.70663.
  6. Dutta D, Jena S, Mahajan K, Kamrul Hasan ABM, Mohindra R, Singla R. Impact of Real Time, Flash and Retrospective Continuous Glucose Monitoring on Feto-Maternal Outcomes in Women With Gestational Diabetes and Pre-Gestational Diabetes: A Systematic Review and Meta-Analysis With Trial Sequential Analysis of Randomized Controlled Trials. Diabetes Obes Metab. 2026 Jul;28(7):5590-5603. doi: 10.1111/dom.70743.
  7. Mahajan K, Dutta D, Kamrul-Hasan ABM, Pradhan A, Vohra S, Mahajan N. Upfront Aspirin-Free Antiplatelet Monotherapy After Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis of Safety and Efficacy. Indian Heart J. 2026 Apr 3:S0019-4832(26)00041-6. doi: 10.1016/j.ihj.2026.04.002.
  8. Ghosh A, Gupta L, Ansari IA, Dutta D, Misra A. High cost and poor availability of continuous glucose monitoring in low-income and middle-income countries. Lancet Diabetes Endocrinol. 2026 Jun 23:S2213-8587(26)00153-1. doi: 10.1016/S2213-8587(26)00153-1.
  9. Kamrul-Hasan ABM, Khalil I, Dutta D, Mahajan K, Nagendra L, Pappachan JM. Comparative Efficacy and Safety of Tirzepatide in Asian and Non-Asian Adults With Obesity Without Diabetes: A Systematic Review and Meta-Analysis. Endocrinol Diabetes Metab. 2026 Jul;9(4):e70291. doi: 10.1002/edm2.70291. PMID: 42487213
  10. Jena S, Dutta D, Mukherjee A, Joshi A, Kamrul-Hasan ABM, Bhattacharya S. Efficacy and Safety of Semaglutide for Managing Antipsychotic-associated Weight Gain: A Systematic Review and Meta-analysis. Indian J Endocrinol Metab. 2026 Mar-Apr;30(2):119-128. doi: 10.4103/ijem.ijem_1037_25.
  11. Mahajan K, Mahajan N, Sharma JB, Himral S, Bhatia T, Dutta D. Changes in lipoprotein(a) and their association with LDL-C in patients with ACS treated with triple oral lipid-lowering therapy. J Clin Lipidol. 2026 Mar 14:S1933-2874(26)00071-1. doi: 10.1016/j.jacl.2026.03.006.
  12. Mahajan K, Dutta D, Kamrul-Hasan ABM, Mahajan N, Sharma J, Himral S, Vohra S, Pradhan A. Safety and Efficacy of Ticagrelor with Aspirin DAPT vs. Aspirin Alone in Patients Undergoing CABG Following ACS: A Systematic Review and Meta-Analysis. Cardiovasc Hematol Disord Drug Targets. 2026 Jul 17. doi: 10.2174/011871529X488257260710041631. Epub ahead of print. PMID: 42474007
  13. Kamrul-Hasan ABM, Khalil I, Mahajan K, Dutta D, Banerjee M, Pappachan JM. Novel Amylin-Based Therapies for Weight Management in Adults With Overweight or Obesity Without Diabetes: A Network Meta-Analysis. Endocrinol Diabetes Metab. 2026 May;9(3):e70247. doi: 10.1002/edm2.70247.
  14. Kamrul-Hasan ABM, Chatterjee S, Ashraf H, Nagendra L, Khalil I, Hasan M, Ahsan A, Dutta D. Efficacy and Safety of the Dual Glucagon-Like Peptide-1 and Glucagon Receptor Agonist Mazdutide in Predominantly Chinese Adults With Obesity and/or Type 2 Diabetes: A Systematic Review and Meta-Analysis. Diabetes Obes Metab. 2026 Jul 6. doi: 10.1111/dom.71058. Epub ahead of print. PMID: 42410325.
  15. Kamrul-Hasan ABM, Uday S, Nagendra L, Dutta D, Bhattacharya S, Pappachan JM, Ashraf AP. Achondroplasia management in the era of targeted therapies: a meta-analysis of C-type natriuretic peptide analogs. J Endocr Soc. 2026 Jun 16;10(7):bvag121. doi: 10.1210/jendso/bvag121.
  16. Jena S, Jindal R, Dutta D, Kamrul-Hasan ABM, Mahajan K. Efficacy and Safety of Oral Semaglutide in the Management of Diabetes and Obesity: A Comprehensive Meta-analysis of Real-world Evidence. touchREV Endocrinol. 2026 May;22(1):16-28. doi: 10.17925/EE.2026.22.1.8.
  17. Kamrul-Hasan ABM, Chatterjee S, Nagendra L, Nair S, Dutta D, Pappachan JM. Safety and efficacy of lorundrostat, an aldosterone synthase inhibitor, in patients with uncontrolled hypertension: A systematic review and meta-analysis. Medicine (Baltimore). 2026 Jun 5;105(23):e49158. doi: 10.1097/MD.0000000000049158.
  18. Kamrul-Hasan ABM, Dutta D, Mahajan K, Nagendra L, Pappachan JM, Bhattacharya S, Kalra S. From Induction to Maintenance? Rethinking GLP-1-Based Obesity Pharmacotherapy in the Era of Oral Agents. Diabetes Obes Metab. 2026 May 31. doi: 10.1111/dom.70922.
  19. Dutta D, Nagendra L, Bhattacharya S, Kamrul-Hasan ABM, Yajnik CS. Parental birth weight as a predictor of neonatal and childhood outcomes in children: a systematic review and meta-analysis. J Dev Orig Health Dis. 2025 Dec 19;17:e1. doi: 10.1017/S2040174425100366. PMID: 41416653.
  20. Dutta D, Kamrul-Hasan ABM, Jindal R, Mohindra R, Nagendra L, Bhattacharya S. Impact of semaglutide use on glycemic and metabolic profile in adults with type 1 diabetes having overweight or obesity: A systematic review and meta-analysis. Medicine (Baltimore). 2025 Dec 12;104(50):e46446. doi: 10.1097/MD.0000000000046446. PMID: 41398803
  21. Dutta D, Kamrul-Hasan ABM, Jena S, Mahajan K, Misra A. Impact of sodium-glucose co-transporter-2 inhibitor combined with mineralocorticoid receptor antagonist therapy versus either agent alone in individuals with chronic kidney disease: A systematic review and meta-analysis. Diabetes Metab Syndr. 2025 Nov;19(11):103334. doi: 10.1016/j.dsx.2025.103334. Epub 2025 Nov 28. PMID: 41330010.
  22. Dutta D, Sharma M, Nagendra L, Bhattacharya S, Mohindra R, Yajnik CS. Long term impact on offspring (5-11 years of age) of metformin use in pregnancy in mothers with diabetes: A systematic review and meta-analysis. Endocr Pract. 2024 Jun 12:S1530-891X(24)00559-7. doi: 10.1016/j.eprac.2024.05.017. Epub ahead of print. [PubMed] PMID: 38876183. [IMPACT FACTOR: 3.7]
  23. Dutta D, Nagendra L, Kumar M, Kamrul-Hasan ABM, Bhattacharya S. Optimal Use of Once-Weekly Basal Insulin Efsitora Alfa in Type 1 and Type 2 Diabetes: A Systematic Review and Meta-Analysis. Endocr Pract. 2024 Dec 20:S1530-891X(24)00872-3. doi: 10.1016/j.eprac.2024.12.013. Epub ahead of print. PMID: 39710291.
  24. Kamrul-Hasan ABM, Ashraf H, Nagendra L, Khalil I, Chatterjee S, Dutta D, Haq T, Alanazi MA, Pappachan JM. Role of Oral Glucagon-Like Peptide-1 Receptor Agonists in Weight Management for Individuals With Overweight or Obesity Without Diabetes: A Network Meta-Analysis of Randomized Controlled Trials. Obes Sci Pract. 2026 Aug 6;12(4):e70181. doi: 10.1002/osp4.70181. PMID: 42564827
  25. Kamrul-Hasan ABM, Mahajan K, Muntahi-Reza A, Dutta D, Nagendra L, Pappachan JM. Letter to the Editor: Vitamin D deficiency and post-transplant diabetes in kidney recipients - opportunity for risk stratification and intervention. World J Nephrol. 2026 Sep 25;15(3):122852. doi: 10.5527/wjn.122852. PMID: 42626270
  26. Dutta D, Bhattacharya S, Nagendra L, Kamrul-Hasan A. One-hour vs Two-hour Postprandial Glucose Targets and Fetomaternal Outcomes in Gestational Diabetes Mellitus: A Systematic Review and Meta-Analysis. Endocr Pract. 2025 Jul;31(7):890-898. doi: 10.1016/j.eprac.2025.05.741. Epub 2025 May 21. PubMed PMID: 40409608.
  27. Dutta D, Jindal R, Raizada N, Nagendra L, Kamrul HA, Sharma M. Efficacy and Safety of Glucagon Like Peptide-1 Receptor Agonism Based Therapies in Obstructive Sleep Apnoea: A Systematic Review and Meta-Analysis. Indian J Endocrinol Metab. 2025 Jan-Feb;29(1):4-12. doi: 10.4103/ijem.ijem_365_24. Epub 2025 Feb 28. PMID: 40181850
  28. Kamrul-Hasan ABM, Chatterjee S, Ashraf H, Nagendra L, Dutta D, Pappachan JM. Cardiovascular Outcomes in Adults With Type 2 Diabetes Treated With Tirzepatide: A Systematic Review and Meta-Analysis of Real-World Studies. Endocr Pract. 2025 Nov 24:S1530-891X(25)01292-3. doi: 10.1016/j.eprac.2025.11.010. Epub ahead of print. PMID: 41297885.
  29. Bhattacharya S, Nagendra L, Dutta D, Kamrul-Hasan ABM. Treatment Versus Observation in Early Gestational Diabetes Mellitus: A Systematic Review and Meta-analysis of Randomized Controlled Trials. J Clin Endocrinol Metab. 2024 Dec 17:dgae878. doi: 10.1210/clinem/dgae878. Epub ahead of print. PMID: 39689014.
  30. Kamrul-Hasan ABM, Mahajan K, Khalil I, Shahriar MN, Nagendra L, Dutta D, Pappachan JM. Safety and Efficacy of Oral PCSK9 Inhibitors in Hypercholesterolemia: A Systematic Review and Network Meta-Analysis. Endocr Pract. 2026 Feb 12:S1530-891X(26)00777-9. doi: 10.1016/j.eprac.2026.02.002.
  31. Dutta D, Kamrul-Hasan ABM, Surana V, Singla R, Khandelwal D, Aggarwal S, Nagendra L, Bhattacharya S. Efficacy and safety of the glucagon receptor antagonist volagidemab in type-1 diabetes: A systematic review and meta-analysis. Ann N Y Acad Sci. 2024 Dec 3. doi: 10.1111/nyas.15262. Epub ahead of print. PMID: 39625039.
  32. Dutta D, Kumar M, Jindal R, Joshi A, Kamrul-Hasan ABM, Bhattacharya S. Hypoglycaemia During Oral Glucose Tolerance Test in Pregnancy and Feto-Maternal Outcomes: A Systematic Review and Meta-Analysis. Indian J Endocrinol Metab. 2025 Jul-Aug;29(4):381-393. doi: 10.4103/ijem.ijem_140_25. Epub 2025 Jul 11. PMID: 40917325
  33. Dutta D, Mohindra R, Kumar M, Banerjee M, Sharma M, Mukhopadhyay S. Cardiovascular safety of gabapentinoids gabapentin & pregabalin: A systematic review. Indian J Med Res. 2025 Apr;161(4):363-374. doi: 10.25259/IJMR_1990_2024. Review. PubMed PMID: 40536375; PubMed Central PMCID: PMC12178190.
  34. Kumar M, Awasthi A, Dutta D, Joshi A, Sharma M. Fenofibrate in Metabolic Dysfunction-associated Steatotic Liver Disease: A Systematic Review and Meta-analysis. Indian J Endocrinol Metab. 2025 May-Jun;29(3):268-275. doi: 10.4103/ijem.ijem_528_24. Epub 2025 Jun 28. Review. PubMed PMID: 40688627; PubMed Central PMCID: PMC12274038.
  35. Kamrul-Hasan ABM, Chatterjee S, Nagendra L, Dutta D, Pappachan JM. Efficacy of tirzepatide in glycemic control and weight management in adults with type 2 diabetes: a systematic review and meta-analysis of real-world studies. Postgrad Med J. 2026 Jan 15:qgaf238. doi: 10.1093/postmj/qgaf238. Epub ahead of print. PMID: 41536268.
  36. Kamrul-Hasan ABM, Dutta D, Nagendra L, Basavarajappa SD, Girijashankar HB, Joshi A, Pappachan JM. Glycemic control, weight-loss effects, and safety of cotadutide in individuals with type 2 diabetes: A systematic review and meta-analysis. World J Diabetes. 2025 Dec 15;16(12):112830. doi: 10.4239/wjd.v16.i12.112830. PMID: 41480597
  37. Kamrul-Hasan ABM, Nagendra L, Ashraf AP, Chatterjee S, Dutta D, Pappachan JM. Safety and efficacy of somapacitan in adults with growth hormone deficiency who were switched from daily growth hormone therapy: A systematic review and meta-analysis. Growth Horm IGF Res. 2025 Nov 17;83:101677. doi: 10.1016/j.ghir.2025.101677. Epub ahead of print. PMID: 41259829.
  38. Thakkar S, Bhattacharya S, Nagendra L, Kapoor N, Dutta D, Kalra S. Foetal Metformin Exposure, Childhood Adiposity and Future Cardiovascular Risk: Can We Connect the Dots? touchREV Endocrinol. 2025 Oct;21(2):15-25. doi: 10.17925/EE.2025.21.2.4. Epub 2025 Oct 24. PMID: 41246123
  39. Dutta D, Kamrul-Hasan ABM, Joshi A, Dhall A, Nagendra L, Sharma M. Efficacy and Safety of Twincretin Survodutide, a Dual Glucagon-Like Peptide-1 and Glucagon Receptor Agonist as an Anti-Obesity and Anti-Diabetes Medication: A Systematic Review and Meta-Analysis. Indian J Endocrinol Metab. 2025 May-Jun;29(3):253-259. doi: 10.4103/ijem.ijem_366_24. Epub 2025 Jun 28. Review. PubMed PMID: 40688625; PubMed Central PMCID: PMC12274044.
  40. Kamrul-Hasan ABM, Shaikh S, Ashraf H, Kuchay MS, Nagendra L, Dutta D, Pappachan JM. Safety and efficacy of sodium-glucose cotransporter-2 inhibitors in adults with type 2 diabetes fasting during Ramadan: A meta-analysis. World J Diabetes. 2026 Feb 15;17(2):115495. doi: 10.4239/wjd.v17.i2.115495
  41. Khalil I, Islam MR, Kamrul-Hasan ABM, Nagendra L, Promi SA, Sayed MA, Rahman MT, Sultana N, Tasmi NA, Das M, Tarannum S, Dey R, Dutta D. Comparative Effectiveness of Glucagon-like Peptide-1- Receptor Agonists in Patients With Heart Failure With Preserved or Minimally Reduced Ejection Fraction: A Comprehensive Bayesian Network Meta-Analysis and Network Meta-Regression. Endocr Pract. 2025 Jun 18;. doi: 10.1016/j.eprac.2025.06.005. [Epub ahead of print] PubMed PMID: 40553959.
  42. Kamrul-Hasan ABM, Bhattacharya S, Ganakumar V, Nagendra L, Dutta D, Aalpona FTZ, Pappachan JM. Trabecular Bone Score in Type 2 Diabetes Mellitus: An Updated Systematic Review and Meta-Analysis. J Clin Densitom. 2025 Jun 10;28(4):101602. doi: 10.1016/j.jocd.2025.101602. [Epub ahead of print] PubMed PMID: 40602155.
  43. Kamrul-Hasan ABM, Ganakumar V, Nagendra L, Dutta D, Islam MR, Pappachan JM. Effect of beinaglutide, a thrice-daily GLP-1 receptor agonist, on body weight and metabolic parameters: A systematic review and meta-analysis. World J Diabetes. 2025 May 15;16(5):103244. doi: 10.4239/wjd.v16.i5.103244. PubMed PMID: 40487607; PubMed Central PMCID: PMC12142189.
  44. Kamrul-Hasan ABM, Kalra A, Kapoor N, Dutta D, Mahajan K, Maskey R, Raza SA. Combination Pharmacotherapies for Obesity-Current Evidence and Future Directions. Endocrinol Diabetes Metab. 2026 Sep;9(5):e70307. doi: 10.1002/edm2.70307. PMID: 42581493
  45. Kamrul-Hasan A, Mondal S, Zahura Aalpona FT, Nagendra L, Dutta D. Role of Sodium-Glucose Cotransporter-2 Inhibitors in Managing Polycystic Ovary Syndrome: A Systematic Review. touchREV Endocrinol. 2025 May;21(1):32-41. doi: 10.17925/EE.2025.21.1.2. Epub 2025 Jan 28. PubMed PMID: 40485656; PubMed Central PMCID: PMC12140633.
  46. Dutta D, Nagendra L, Kamrul-Hasan A, Mahajan K. Efficacy and Safety of Early Initiation of Sodium-Glucose Co-transporter-2 Inhibitors Following Acute Myocardial Infarction: A Systematic Review and Meta-analysis. touchREV Endocrinol. 2025 May;21(1):14-23. doi: 10.17925/EE.2025.21.1.1. Epub 2025 Feb 7. PubMed PMID: 40485654; PubMed Central PMCID: PMC12140638.
  47. Bhattacharya S, Kalra S, Nagendra L, Dutta D. Forty-four Years of the UK Prospective Diabetes Study: Legacy Effect and Beyond. touchREV Endocrinol. 2025 May;21(1):2-3. doi: 10.17925/EE.2025.21.1.8. Epub 2024 Nov 20. PubMed PMID: 40485651; PubMed Central PMCID: PMC12140635.
  48. Dutta D, Mohindra R, Mahajan K, Sharma M. Performance of Fast-Acting Aspart Insulin as Compared to Aspart Insulin in Insulin Pump for Managing Type 1 Diabetes Mellitus: A Meta-Analysis. Diabetes Metab J. 2022 Jun 24. doi: 10.4093/dmj.2022.0035. [PubMed] PMID: 35746893 [IMPACT FACTOR: 5.38]
  49. Dutta D, Kamrul-Hasan ABM, Mondal E, Nagendra L, Joshi A, Bhattacharya S. Role of Resmetirom, a Liver-Directed, Thyroid Hormone Receptor Beta-Selective Agonist, in Managing Nonalcoholic Steatohepatitis: A Systematic Review and Meta-Analysis. Endocr Pract. 2024 May 1:S1530-891X(24)00506-8. doi: 10.1016/j.eprac.2024.04.016 [PubMed] PMID: 38697306 [IMPACT FACTOR: 3.7]
  50. Kamrul-Hasan ABM, Pappachan JM, Dutta D, Nagendra L, Kuchay MS, Kapoor N. Reasons for discontinuing tirzepatide in randomized controlled trials: A systematic review and meta-analysis. World J Diabetes. 2025 Apr 15;16(4):101731. doi: 10.4239/wjd.v16.i4.101731. PMID: 40236848 [PubMed]
  51. Kamrul-Hasan ABM, Alam MS, Dutta D, Sasikanth T, Aalpona FTZ, Nagendra L. Tirzepatide and Cancer Risk in Individuals with and without Diabetes: A Systematic Review and Meta-Analysis. Endocrinol Metab (Seoul). 2025 Jan 15. doi: 10.3803/EnM.2024.2164. Epub ahead of print. PMID: 39814031.
  52. Kamrul-Hasan ABM, Borozan S, Dutta D, Nagendra L, Shrestha D, Pappachan JM. Neuropsychiatric effects of tirzepatide: a systematic review and meta-analysis.Endocr Pract. 2024 Dec 27:S1530-891X(24)00877-2. doi: 10.1016/j.eprac.2024.12.017. Epub ahead of print. PMID: 39733942.
  53. Dutta D, Nagendra L, Chandran M, Sharma M, Bhattacharya S, Mukhopadhyay S. Impact of pheochromocytoma or paraganglioma on bone metabolism: A systemic review and meta-analysis. J Clin Densitom. 2024 May 10;27(3):101501. doi: 10.1016/j.jocd.2024.101501. [PubMed] PMID: 38796986 [IMPACT FACTOR: 2.5]
  54. Mahajan K, Nagendra L, Dhall A, Dutta D. Impact of early initiation of ezetimibe in patients with acute coronary syndrome: A systematic review and meta-analysis. Eur J Intern Med. 2024 Feb 8:S0953-6205(24)00049-9. doi: 10.1016/j.ejim.2024.02.004. [PubMed] PMID: 38336550 [IMPACT FACTOR: 8.0]
  55. Bhattacharya S, Nagendra L, Dutta D, Mondal S, Bhat S, Raj JM, Boro H, Kamrul-Hasan ABM, Kalra S. First-trimester fasting plasma glucose as a predictor of subsequent gestational diabetes mellitus and adverse fetomaternal outcomes: A systematic review and meta-analysis. Diabetes Metab Syndr. 2024 Jun 1;18(6):103051. doi: 10.1016/j.dsx.2024.103051. Epub ahead of print. PMID: 38843646. [IMPACT FACTOR: 10]
  56. Dutta D, Nagendra L, Harish BG, Sharma M, Joshi A, Hathur B, Kamrul-Hasan A. Efficacy and Safety of Cagrilintide Alone and in Combination with Semaglutide (Cagrisema) as Anti-Obesity Medications: A Systematic Review and Meta-Analysis.Indian J Endocrinol Metab. 2024 Sep-Oct;28(5):436-444. doi: 10.4103/ijem.ijem_45_24. Epub 2024 Sep 4. PMID: 39676787; PMCID: PMC11642503.
  57. Nagendra L, Chandran M, Reginster JY, Bhadada SK, Bhattacharya S, Dutta D, Hiligsmann M. Cost-effectiveness of FRAX®-based intervention thresholds for management of osteoporosis in Indian women: a Markov microsimulation model analysis. Osteoporos Int. 2024 Dec 27. doi: 10.1007/s00198-024-07328-6. Epub ahead of print. PMID: 39730734
  58. Dutta D, Mahajan K, Verma L, Gupta G, Sharma M. Gender differences in the management and outcomes of acute coronary syndrome in indians: A systematic review and meta-analysis. Indian Heart J. 2024 Sep-Oct;76(5):333-341
  59. Kamrul-Hasan ABM, Dutta D, Nagendra L, Kuchay MS, Islam MS, Pappachan JM. Hepatobiliary effects and safety of tirzepatide: A systematic review and meta-analysis. Diabetes Obes Metab. 2024 Dec;26(12):6074-6079. PMID: 39268951
  60. Kamrul-Hasan ABM, Pappachan JM, Nagendra L, Akter N, Jena S, Dutta D, Nair S. Role of automated insulin delivery in managing insulin-treated outpatients with type 2 diabetes: A systematic review and meta-analysis. World J Diabetes. 2025 Oct 15;16(10):111230. doi: 10.4239/wjd.v16.i10.111230. PMID: 41113485
  61. Dutta D, Kamrul-Hasan ABM, Nagendra L, Bhattacharya S. Efficacy and Safety of Novel Twincretin Tirzepatide, a Dual GIP/GLP-1 Receptor Agonist, as an Anti-obesity Medicine in Individuals Without Diabetes: A Systematic Review and Meta-analysis. touchREV Endocrinol. 2024 Oct;20(2):72-80. PMID: 39526060
  62. Kamrul-Hasan A, Mondal S, Nagendra L, Sasikanth T, Ahammed A, Rahman S, Wickramarachchi A, Parajuli N, Khatiwada S, Dutta D. Role of Obeticholic Acid, a Farnesoid X Receptor Agonist, in Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis. touchREV Endocrinol. 2024 Oct;20(2):54-61. PMID: 39526049
  63. Thakkar S, Kantroo V, Nagendra L, Dutta D, Kamrul-Hasan ABM, Kalra S, Bhattacharya S. Endocrine consequences of antifungal therapy: A missed entity. World J Clin Cases. 2026 Jan 16;14(2):117140. doi: 10.12998/wjcc.v14.i2.117140. PMID: 41608146
  64. Kamrul-Hasan ABM, Pappachan JM, Jethwani P, Patra S, Nagendra L, Dutta D, Khan MDJ, Bhattacharya S. Metformin use & asthma outcomes in patients with concurrent diabetes & bronchial asthma: A systematic review & meta-analysis. Indian J Med Res. 2025 Aug;162(2):187-196. doi: 10.25259/IJMR_431_2025. PMID: 41100655
  65. Kamrul-Hasan ABM, Chatterjee S, Nagendra L, Patra S, Dutta D, Aljaberi A, Pappachan JM. Efficacy and Safety of Once-Weekly IcoSema in Adults With Type 2 Diabetes: A Systematic Review and Meta-Analysis. AACE Endocrinol Diabetes. 2025 Aug 8;12(3):153-161. doi: 10.1016/j.aed.2025.07.012. PMID: 41048697
  66. Kamrul-Hasan ABM, Borozan S, Jena S, Nagendra L, Dutta D, Bhattacharya S, Islam MS, Pappachan JM. Safety and efficacy of efruxifermin in metabolic dysfunction-associated steatohepatitis: A systematic review. World J Gastrointest Pharmacol Ther. 2025 Sep 5;16(3):110709. doi: 10.4292/wjgpt.v16.i3.110709. PMID: 40937291
  67. Kamrul-Hasan ABM, Ashraf H, Nagendra L, Dutta D, Shahriar MN, Islam MS, Pappachan JM. Impacts of Ramadan Fasting on Metabolic and Hepatic Endpoints in Individuals With Metabolic Dysfunction-Associated Fatty Liver Disease: A Systematic Review and Meta-Analysis. JGH Open. 2025 Aug 25;9(8):e70264. doi: 10.1002/jgh3.70264. PMID: 40862239
  68. Kamrul-Hasan ABM, Pappachan JM, Nagendra L, Muthukuda D, Dutta D, Bhattacharya S, Shrestha D, Dhakal GP, Sumanatilleke M, Raza SA, Kalra S. Prevalence of diabetes distress among people with type 2 diabetes in South Asia: A systematic review and meta-analysis. World J Diabetes. 2025 Aug 15;16(8):109352. doi: 10.4239/wjd.v16.i8.109352. PMID: 40837336
  69. Kamrul-Hasan ABM, Pappachan JM, Ashraf H, Nagendra L, Dutta D, Kuchay MS, Shaikh S. Safety and efficacy of glucagon-like peptide-1 receptor agonists in individuals with type 2 diabetes mellitus fasting during Ramadan: a systematic review and meta-analysis. World J Methodol. 2025 Dec 20;15(4):105478. doi: 10.5662/wjm.v15.i4.105478. PMID: 40900863
  70. Kamrul-Hasan ABM, Mondal S, Nagendra L, Dutta D, Bhattacharya S, Pappachan JM. Safety of esaxerenone (CS-3150) and its impacts on blood pressure and renal function: A systematic review and meta-analysis. Medicine (Baltimore). 2025 Aug 1;104(31):e43615. doi: 10.1097/MD.0000000000043615. PMID: 40760566
  71. Mahajan K, Batra A, Gupta A, Arora S, Sharma JB, Himral S, Dutta D. Adding Ezetimibe to High-Intensity Statin at the Time of Admission in Patients With Acute Coronary Syndrome: Results From the Optimization of Low-Density Lipoprotein Cholesterol After Acute Coronary Syndrome (OLA) Study. Cureus. 2025 Aug 6;17(8):e89513. doi: 10.7759/cureus.89513. PMID: 40777069
  72. Kamrul-Hasan ABM, Borozan S, Fernandez CJ, Dutta D, Nagendra L, Pappachan JM. Thrice-Weekly Insulin Degludec Versus Once-Daily Insulin Glargine in Insulin-Naïve Patients With Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis. Br J Hosp Med (Lond). 2025 Jul 25;86(7):1-16. doi: 10.12968/hmed.2024.0716.
  73. Singla R, Dutta D, Surana V, Gupta G, Bhattacharya S, Dhingra A, Agarwal S, Chittawar S, Khandelwal D, Kalra S, Gupta Y, Tandon N. Development and Implementation of a Nationwide Structured Education Programme for Type 1 Diabetes in India: The T1DE Initiative. Indian J Endocrinol Metab. 2025 Sep-Oct;29(5):548-554. doi: 10.4103/ijem.ijem_192_25. Epub 2025 Oct 25. PMID: 41229727
  74. Nagendra L, Agarwal K, Patra S, Bhattacharya S, Gupta L, Talwar N, Rao A, Gupta A, Kamrul-Hasan ABM, Dutta D, Hiligsmann M, Chandran M. Optimizing Bone Health in Diabetes: Strategies for Fracture Risk Reduction in Public Healthcare. Curr Diab Rep. 2025 Jul 21;25(1):43. doi: 10.1007/s11892-025-01599-x. PMID: 40690104
  75. Kumar A, Kuchay MS, Ghosh A, Gulati S, Choudhary NS, Dutta D, Sharma P, Vikram NK, Misra A. India-Specific Consensus on MASLD in Type 2 Diabetes: Bridging Global Guidelines to Local Realities. Diabetes Care. 2025 Nov 1;48(11):e153-e154. doi: 10.2337/dc25-1319. PMID: 41115226
  76. Kumar A, Khandelwal D, Gupta L, Agrawal U, Mittal S, Aggarwal V, Damle NA, Garg M, Dutta D, Kalra S. Clinical and Biochemical Profiles of Hospitalized Patients with Hypercalcaemia from a Tertiary Care Centre in North India. touchREV Endocrinol. 2024 Oct;20(2):119-123. PMID: 39526047
  77. Dutta D, Nagendra L, Joshi A, Krishnasamy S, Sharma M, Parajuli N. Glucagon-Like Peptide-1 Receptor Agonists in Post-bariatric Surgery Patients: A Systematic Review and Meta-analysis. Obes Surg. 2024 Mar 19. doi: 10.1007/s11695-024-07175-8. [PubMed] PMID: 38502519. [IMPACT FACTOR: 3.3]
  78. Dutta D, Nagendra L, Joshi A, Krishnasamy S, Sharma M, Parajuli N. Adjuvant Role of Glucagon-Like Peptide-1 Receptor Agonist-Based Therapies for Sustained Weight Loss in Post-bariatric Surgery Patients. Obes Surg. 2024 Apr 15. doi: 10.1007/s11695-024-07230-4. [PubMed] PMID: 38616240 [IMPACT FACTOR: 3.3]
  79. Kamrul-Hasan ABM, Mondal S, Dutta D, Nagendra L, Kabir MR, Pappachan JM. Pancreatic Safety of Tirzepatide and Its Effects on Islet Cell Function: A Systematic Review and Meta-Analysis. Obes Sci Pract. 2024 Dec 24;10(6):e70032. doi: 10.1002/osp4.70032. PMID: 39720158; PMCID: PMC11667760.
  80. Nagendra L, Dutta D, Bg H, Khandelwal D, Lathia T, Sharma M. Safety and tolerability of sodium glucose cotransporter-2 inhibitors in children and young adults: A systematic review and meta-analysis. Ann Pediatr Endocrinol Metab. 2024 Jan 2. doi: 10.6065/apem.2346162.081. [PubMed] PMID: 38163851 [IMPACT FACTOR: 2.2]
  81. Misra A, Kumar A, Kuchay MS, Ghosh A, Gulati S, Choudhary NS, Dutta D, Sharma P, Vikram NK; Delphi Committee. Consensus guidelines for the diagnosis and management of metabolic dysfunction-associated steatotic liver disease in adult Asian Indians with type 2 diabetes. Diabetes Metab Syndr. 2025 Mar;19(3):103209. doi: 10.1016/j.dsx.2025.103209. PMID: 40222341.
  82. Dutta D, Kumar M, Joshi A, Sharma M. Safety of Rapid Intermittent Bolus versus Slow Continuous Infusion of Hypertonic Saline for Managing Symptomatic Severe Hyponatremia: A Systematic Review and Meta-analysis. Ann Afr Med. 2025 Apr 1;24(2):431-437. doi: 10.4103/aam.aam_249_24. PMID: 40053429
  83. Kamrul-Hasan ABM, Alam MS, Talukder SK, Hannan MA, Dutta D, Nagendra L, Selim S. Efficacy and Safety of Ertugliflozin Compared to Placebo in Patients With Type 2 Diabetes: An Updated Systematic Review and Meta-Analysis. J Diabetes Res. 2024 Sep 24;2024:5553327. doi: 10.1155/2024/5553327. PMID: 39354951
  84. Kamrul-Hasan ABM, Mondal S, Nagendra L, Yadav A, Aalpona FTZ, Dutta D. Role of teplizumab, a humanized anti-CD3 monoclonal antibody, in managing newly diagnosed type 1 diabetes: an updated systematic review and meta-analysis. Endocr Pract. 2024 Mar 20:S1530-891X(24)00084-3. doi: 10.1016/j.eprac.2024.03.006. Epub ahead of print. [PubMed] PMID: 38519028. [IMPACT FACTOR: 4.2]
  85. Dutta D, Harish BG, Anne B, Nagendra L. Role of novel sodium glucose co-transporter-2 inhibitor enavogliflozin in type-2 diabetes: A systematic review and meta-analysis. Diabetes Metab Syndr. 2023 Jul 3;17(8):102816. doi: 10.1016/j.dsx.2023.102816. [PubMed] PMID: 37421885. [IMPACT FACTOR: 10]
  86. Dutta D, Kadian J, Mahajan K, Dhall A, Sharma M. Efficacy and safety of luseogliflozin in improving glycaemic and non-glycaemic outcomes in type-2 diabetes: A meta-analysis. Diabetes Metab Syndr. 2023 Mar 13;17(3):102742. doi: 10.1016/j.dsx.2023.102742 [IMPACT FACTOR: 10]
  87. Kamrul-Hasan ABM, Hannan MA, Alam MS, Aalpona FTZ, Nagendra L, Selim S, Dutta D. Role of flibanserin in managing hypoactive sexual desire disorder in women: A systematic review and meta-analysis. Medicine (Baltimore). 2024 Jun 21;103(25):e38592. doi: 10.1097/MD.0000000000038592. PMID: 38905407. [IMPACT FACTOR: 1.6]
  88. Kamrul-Hasan ABM, Selim S, Afsana F, Nagendra L, Ahmed R, Dutta D. Once-Weekly Tirzepatide Versus Once-Daily Basal Insulin in Managing Type 2 Diabetes Inadequately Controlled With Oral anti-Hyperglycemic Drugs: A Systematic Review and Meta-Analysis. Endocr Pract. 2024 Dec 11:S1530-891X(24)00861-9. doi: 10.1016/j.eprac.2024.12.005. Epub ahead of print. PMID: 39672540
  89. Kamrul-Hasan ABM, Dutta D, Nagendra L, Bhattacharya S, Singla R, Kalra S. Efficacy and safety of albiglutide, a once-weekly glucagon-like peptide-1 receptor agonist, in patients with type 2 diabetes: A systematic review and meta-analysis. Medicine (Baltimore). 2024 Jun 21;103(25):e38568. doi: 10.1097/MD.0000000000038568. PMID: 38905435. [IMPACT FACTOR: 1.6]
  90. Dutta D, Chatterjee S, Datta PK, Mohindra R, Sharma M. Role of Novel Glucagon-like Peptide-1 Receptor Analogue Polyethylene Glycol Loxenatide in Type 2 Diabetes: A Systematic Review and Meta-analysis. Indian J Endocrinol Metab. 2023 Sep-Oct;27(5):377-386. doi: 10.4103/ijem.ijem_162_23. [PubMed] PMID: 38107730
  91. Patra S,Dutta D, Nagendra L, Raizada N. Efficacy and safety of levoketoconazole in managing Cushing’s syndrome: A systematic review. Indian J Endocr Metab 2024;28:343-9. [PubMed]
  92. Dutta D, Nagendra L, Mohindra R, Bhattacharya S, Joshi A, Kamrul‑Hasan AB. Role of growth hormone therapy in metabolic‑dysfunction‑associated steatotic liver disease: A systematic review and meta‑analysis. Indian J Endocr Metab 2024;28:336-42. [PubMed]
  93. Dutta D, Kadian J, Maisnam I, Kumar A, Bhattacharya S, Sharma M. Efficacy and Safety of Novel Thiazolidinedione Rivoglitazone in Type-2 Diabetes a Meta-Analysis. Indian J Endocrinol Metab. 2023 Jul-Aug;27(4):286-295. doi: 10.4103/ijem.ijem_17_23. Epub 2023 Aug 28. [PubMed] PMID: 37867986
  94. Kamrul-Hasan ABM, Dutta D, Nagendra L, Mondal S, Bhattacharya S, Kalra S. Safety and efficacy of the novel RNA interference therapies for hypertriglyceridemia and mixed hyperlipidemia management: a systematic review and meta-analysis. Endocr Pract. 2024 Sep 5:S1530-891X(24)00662-1. doi: 10.1016/j.eprac.2024.08.013. [PubMed] [IMPACT FACTOR: 3.7]
  95. Dutta D, Nagendra L, Anne B, Kumar M, Sharma M, Kamrul-Hasan ABM. Orforglipron, a novel non-peptide oral daily glucagon-like peptide-1 receptor agonist as an anti-obesity medicine: A systematic review and meta-analysis. Obes Sci Pract. 2024 Feb 26;10(2):e743. doi: 10.1002/osp4.743. [PubMed] PMID: 38414573 [IMPACT FACTOR: 3.6]
  96. Patra S,Dutta D, Kalra S. Metabolomics in Endocrinology: The Way Forward. Indian J Endocrinol Metab. 2025 Jul-Aug;29(4):394-401. doi: 10.4103/ijem.ijem_488_24. Epub 2025 Aug 26. PMID: 40917314;
  97. Nagendra L, Dutta D, Raizada N, Surana V, Selvan C, Bhattacharya S. Efficacy and Safety of Osilodrostat in Managing Cushing's Syndrome: A Systematic Review and Meta-Analysis. Indian J Endocrinol Metab. 2024 May-Jun;28(3):232-238. doi: 10.4103/ijem.ijem_260_23. Epub 2024 Jun 26. [PubMed] PMID: 39086571
  98. Nagendra L, Dutta D, Mondal S, Kapoor N, Joshi A, Bhattacharya S. Hyperprolactinemia Due to Prolactinoma has an Adverse Impact on Bone Health with Predominant Impact on Trabecular Bone: A Systematic Review and Meta-Analysis. J Clin Densitom. 2023 Nov 25;27(1):101453. doi: 10.1016/j.jocd.2023.101453. [PubMed] PMID: 38064881. [IMPACT FACTOR: 2.5]
  99. Priya G, Kotwal N, Madhu SV, Patra S, Pandit K, Anne B, Shenoy MT, Swain J, Das S, Kopalle LN, Nagendra L, Bhattacharya S, Shaikh SS, Mondal S, Bhat GK, Joshi A, Kalra S, Biswas K, Kumar HKVS, Mishra SK, Dutta D, Kapoor N, Mittal S. Endocrine Society of India's National White Paper on Endocrine Disrupting Chemicals - A Call for Action. Indian J Endocrinol Metab. 2026 Jan-Feb;30(1):4-19. doi: 10.4103/ijem.ijem_976_25. Epub 2026
  100. Kamrul-Hasan ABM, Dutta D, Nagendra L, Sharma M, Patra S, Bhattacharya S. Role of anagliptin, a dipeptidyl peptidase-4 inhibitor, in managing type 2 diabetes: A systematic review and meta-analysis. Medicine (Baltimore). 2024 Jul 12;103(28):e38870. doi: 10.1097/MD.0000000000038870. [PubMed] PMID: 38996148[IMPACT FACTOR: 1.5]
  101. Pande AK, Dutta D, Singla R. Prevention of Type 1 Diabetes: Current Perspective. Indian J Endocrinol Metab. 2023 Jul-Aug;27(4):277-285. doi: 10.4103/ijem.ijem_78_23. Epub 2023 Aug 28. [PubMed] PMID: 37867976
  102. Kamrul-Hasan A, Patra S, Dutta D, Nagendra L, Muntahi-Reza A, Borozan S, Pappachan JM. Renal effects and safety of tirzepatide in subjects with and without diabetes: A systematic review and meta-analysis. World J Diabetes. 2025 Feb 15;16(2):101282. PMID: 39959269
  103. Sharma M, Das SK, Mohindra R, Dutta D. Efficacy and Safety of Tocilizumab in Polymyalgia Rheumatica: A Systematic Review and Meta-Analysis. Int J Rheum Dis. 2025 Feb;28(2):e70106. PMID: 39895497.
  104. Sharma LK, Datta RR, Aggarwal A, Sharma N, Dutta D. Macrolipasemia variant of macroenzymes: An endocrine laboma. Natl Med J India. 2024 Jan-Feb;37(1):28-29. doi: 10.25259/NMJI_161_21. [PubMed] PMID: 39096232. [IMPACT FACTOR: 0.5]
  105. Nagendra L, Dutta D, Kamrul-Hasan ABM. Bariatric surgery and tirzepatide-Friends, not foes! Diabetes Obes Metab. 2024 Jul 8. doi: 10.1111/dom.15778. [PudMed] PMID: 38978177 [IMPACT FACTOR: 5.4]
  106. Kamrul-Hasan ABM, Pappachan JM, Nagendra L, Ashraf H, Dutta D, Bhattacharya S, Kapoor N. Metabolic outcomes of bariatric surgery versus lifestyle intervention in adolescents with severe obesity: A systematic review and meta-analysis. Clin Obes. 2025 Mar 6:e70008. doi: 10.1111/cob.70008. PMID: 40049152.
  107. Nagendra L, Dutta D, Mondal S, Yadav A, Aalpona FTZ, Kamrul-Hasan ABM. Reply to the Letter to the Editor, Endocrine Practice for "Role of Teplizumab, a Humanized Anti-CD3 Monoclonal Antibody, in Managing Newly Diagnosed Type 1 Diabetes: An Updated Systematic Review and Meta-Analysis". Endocr Pract. 2024 Jul 9:S1530-891X(24)00602-5. [PubMed] PMID: 38992797 [IMPACT FACTOR: 3.7]
  108. Dutta D, Nagendra L, Bhat S, Mohindra R, Surana V, Misra A. Optimal use of once weekly icodec insulin in type-2 diabetes: An updated meta-analysis of phase-2 and phase-3 randomized controlled trials. Diabetes Metab Syndr. 2023 Oct;17(10):102877. doi: 10.1016/j.dsx.2023.102877. Epub 2023 Oct 11. [PubMed] PMID: 37832481.
  109. Bhattacharya S, Nagendra L, Chandran M, Kapoor N, Patil P, Dutta D, Kalra S. Trabecular bone score in adults with type 1 diabetes: a meta-analysis. Osteoporos Int. 2023 Oct 11. doi: 10.1007/s00198-023-06935-z. Epub ahead of print. [PubMed] PMID: 37819402. [IMPACT FACTOR: 4.6]
  110. Dutta D, Mohindra R, Kumar M, Kumar A, Sharma M. Ranirestat Improves Electrophysiologic but not Clinical Measures of Diabetic Polyneuropathy: A Meta-Analysis. Indian J Endocrinol Metab. 2022 Sep-Oct;26(5):399-406. [PubMed] PMID: 36618527
  111. Dutta D, Bhattacharya S, Kumar M, Datta PK, Mohindra R, Sharma M. Efficacy and safety of novel thiazolidinedione lobeglitazone for managing type-2 diabetes a meta-analysis. Diabetes Metab Syndr. 2022 Dec 23;17(1):102697. doi: 10.1016/j.dsx.2022.102697 [PubMed] PMID: 36580702 [IMPACT FACTOR: 10]
  112. Dutta D, Khandelwal D, Kumar M, Sharma M. Efficacy and safety of novel dual glucokinase activator dorzagliatin in type-2 diabetes A meta-analysis. Diabetes Metab Syndr. 2022 Dec 20;17(1):102695. doi: 10.1016/j.dsx.2022.102695. [PubMed] PMID: 36566614 [IMPACT FACTOR: 10]
  113. Nagendra L, Bg H, Sharma M, Dutta D. Semaglutide and cancer: A systematic review and meta-analysis. Diabetes Metab Syndr. 2023 Jul 26;17(9):102834. doi: 10.1016/j.dsx.2023.102834. [PubMed] PMID: 37531876 [IMPACT FACTOR: 10]
  114. Nagendra L, Mahajan K, Gupta G, Dutta D. Impact of early initiation of proprotein convertase subtilisin/kexin type 9 inhibitors in patients with acute coronary syndrome: A systematic review meta-analysis. Indian Heart J. 2023 Sep 29:S0019-4832(23)00164-5. doi: 10.1016/j.ihj.2023.09.005. [PubMed] PMID: 37777180
  115. Nagendra L, Dutta D, Sharma M, Harish BG. Impact of enhanced external counter-pulsation therapy on glycaemic control in people with prediabetes and type-2 diabetes: A systematic review and meta-analysis.touchREVIEWS in Endocrinology 2023 http://doi.org/10.17925/EE.2023.19.2.8
  116. Dutta D, Kumar M, Shivaprasad KS, Kumar A, Sharma M. Impact of semaglutide on biochemical and radiologic measures of metabolic-dysfunction associated fatty liver disease across the spectrum of glycaemia: A meta-analysis. Diabetes Metab Syndr. 2022 Jun;16(6):102539. doi: 10.1016/j.dsx.2022.102539. [PubMed] PMID: 35709586 [IMPACT FACTOR: 10]
  117. Mukhopadhyay S, Dutta D. Strategies to build stronger bones in Indian children: Challenges for implementation. Indian J Med Res. 2024 Mar & Apr;159(3 & 4):315-321. doi: 10.25259/IJMR_233_2024. PMID: 39361795
  118. Dutta D, Khandelwal D. Lifestyle interventions reduce the risk of type-2 diabetes through decreasing branched-chain amino acids: newer insights. J Clin Endocrinol Metab. 2022 Oct 28:dgac633. doi: 10.1210/clinem/dgac633. Epub ahead of print. [PubMed] PMID: 3630554 [IMPACT FACTOR: 5.6]
  119. Dutta D, Agarwal A, Maisnam I, Singla R, Khandelwal D, Sharma M. Efficacy and Safety of the Novel Dipeptidyl Peptidase-4 Inhibitor Gemigliptin in the Management of Type 2 Diabetes: A Meta-Analysis. Endocrinol Metab (Seoul). 2021 Apr 6. doi: 10.3803/EnM.2020.818. [PubMed] PMID: 33820392 [IMPACT FACTOR: 3.26]
  120. Dutta D, Nagendra L, Bhattacharya S, Sharma M. Efficacy and Safety of Ultra-rapid Lispro Insulin in Managing Type-1 and Type-2 Diabetes: A Systematic Review and Meta-Analysis. Indian J Endocrinol Metab. 2023 Nov-Dec;27(6):467-475. doi: 10.4103/ijem.ijem_225_23. [PubMed] PMID: 38371177
  121. Kamrul-Hasan ABM, Alam MS, Talukder SK, Dutta D, Selim S. Efficacy and Safety of Omarigliptin, a Novel Once-Weekly Dipeptidyl Peptidase-4 Inhibitor, in Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis. Endocrinol Metab (Seoul). 2024 Jan 23. doi: 10.3803/EnM.2024.1839. [PubMed] PMID: 38254293 [IMPACT FACTOR: 3.26]
  122. Bhat S, Mondal S, Nagendra L, Bhattacharya S, Boro H, Dutta D, Kalra S, Bhadada SK, Sahay RK, Kumar HK. Unraveling BURnout Determinants among ENdocrinologists in Indian conText (UNBURDEN-IT). Indian J Endocrinol Metab. 2025 Jan-Feb;29(1):116-124. doi: 10.4103/ijem.ijem_491_23. PMID: 40181856
  123. Priya G, Laway BA, Ayyagari M, Gupta M, Bhat GHK, Dutta D. The Glucocorticoid Taper: A Primer for the Clinicians. Indian J Endocrinol Metab. 2024 Jul-Aug;28(4):350-362. doi: 10.4103/ijem.ijem_410_23. Epub 2024 Aug 28. PMID: 39371659
  124. Dutta D, Lakshmi N, Raizada N, Bhattacharya S, Sharma M. Verapamil improves One-Year C-Peptide Levels in Recent Onset Type-1 Diabetes: A Meta-Analysis. Indian J Endocrinol Metab. 2023 May-Jun;27(3):192-200 DOI: 10.4103/ijem.ijem_122_23
  125. Dutta D, Surana V, Bhattacharya S, Aggarwal S, Sharma M. Efficacy and Safety of Novel Non-steroidal Mineralocorticoid Receptor Antagonist Finerenone in the Management of Diabetic Kidney Disease: A Meta-analysis. Indian J Endocrinol Metab. 2022 May-Jun;26(3):198-205. [PubMed] PMID: 36248038
  126. Dutta D, Surana V, Singla R, Aggarwal S, Sharma M. Efficacy and safety of novel twincretin tirzepatide a dual GIP and GLP-1 receptor agonist in the management of type-2 diabetes: A Cochrane meta-analysis. Indian J Endocrinol Metab. 2021 Nov-Dec;25(6):475-489. doi: 10.4103/ijem.ijem_423_21. Epub 2022 Feb 17. PMID: 35355921
  127. Dutta D, Mohindra R, Surana V, Sharma M. Safety and efficacy of once weekly dipeptidyl-peptidase-4 inhibitor trelagliptin in type-2 diabetes: A meta-analysis. Diabetes Metab Syndr. 2022 Mar 21;16(4):102469. doi: 10.1016/j.dsx.2022.102469. Epub ahead of print. PMID: 35344848. [IMPACT FACTOR: 10]
  128. Dutta D, Jindal R, Mehta D, Kumar M, Sharma M. Efficacy and safety of hydroxychloroquine for managing glycemia in type-2 diabetes: A systematic review and meta-analysis. J Postgrad Med 2022;68:85-92 [IMPACT FACTOR: 1.10]
  129. Dutta D, Singla R, Surana V, Sharma M. Efficacy and Safety of Letrozole in the Management of Constitutional Delay in Growth and Puberty: A Systematic Review and Meta-analysis. J Clin Res Pediatr Endocrinol. 2021 Sep 3. doi: 10.4274/jcrpe.galenos.2021.2021.0169. [PubMed] PMID: 34477355 [IMPACT FACTOR: 2.15]
  130. Dutta D, Mahajan K, Kumar M, Sharma M. Efficacy and safety of long-acting growth hormone in adult growth hormone deficiency: A systematic review and meta-analysis. Diabetes Metab Syndr. 2022 Feb;16(2):102421. doi: 10.1016/j.dsx.2022.102421. Epub 2022 Feb 8. PMID: 35158212. [IMPACT FACTOR: 10]
  131. Dutta D, Khandelwal D, Jain D, Chahal S, Kuniyal P, Gupta L, Sharma M, Agarwal S. Predictors of quality of life in people living with type-1 and type-2 diabetes: An Indian perspective study and systematic review. Clinical Diabetology 2021 DOI: 10.5603/DK.a2021.0057
  132. Dutta D, Jindal R, Kumar M, Mehta D, Dhall A, Sharma M. Efficacy and safety of once weekly thyroxine as compared to daily thyroxine in managing primary hypothyroidism: A systematic review and meta-analysis. Indian J Endocr Metab 2021;25:76-85 [PubMed] PMID: 34660234 [IMPACT FACTOR: 1.7]
  133. Dutta D, Jindal R, Mehta D, Khandelwal D, Sharma M. Efficacy and safety of novel sodium glucose cotransporter-2 inhibitor remogliflozin in the management of type 2 diabetes mellitus: A systematic review and meta-analysis. Diabetes Metab Syndr. 2021;15(6):102315. doi: 10.1016/j.dsx.2021.102315. [PubMed] PMID: 34700292 [IMPACT FACTOR: 10]
  134. Dutta D, Mohindra R, Misra A. Comment on: "Efficacy and Safety of Saroglitazar in Patients with Cardiometabolic Diseases: A Systematic Review and Meta-Analysis of Randomized Controlled Trials". Clin Drug Investig. 2023 Jan 13. doi: 10.1007/s40261-022-01245-4 [PubMed] PMID: 36637687 [IMPACT FACTOR: 3.58]
  135. Attri B, Nagendra L, Dutta D, Shetty S, Shaikh S, Kalra S, Bhattacharya S. Prandial Insulins: A Person-Centered Choice. Curr Diab Rep. 2024 Apr 3. doi: 10.1007/s11892-024-01540-8. [PubMed] PMID: 38568467 [IMPACT FACTOR: 5.7]
  136. Dutta D, Sharma M, Aggarwal S, Agarwal A, Dhall A. Treatment outcomes of graded dose of empagliflozin in type-2 diabetes: A real world study. Ann Afr Med. 2022 Jan-Mar;21(1):26-33. doi: 10.4103/aam.aam_69_20. PMID: 35313401
  137. Kamrul‑Hasan AB, Talukder SK, Nagendra L, Alam MS, Aalpona FT, Dutta D, et al. Effect of moringa oleifera leaf extract on glycemic parameters in patients with type 2 diabetes mellitus and prediabetes: A systematic review and meta‑analysis. Bangladesh J Endocrinol Metab 2023;2:134-45.
  138. Sharma LK, Dutta D, Sharma N, Kulshreshtha B, Lal S, Sethi R. Prevalence of Macroprolactinemia in People Detected to Have Hyperprolactinemia. J Lab Physicians 2021 DOI: 10.1055/s-0041-1732490
  139. Dutta D, Bhattacharya S, Surana V, Aggarwal S, Singla R, Khandelwal D, Sharma M. Efficacy and safety of saroglitazar in managing hypertriglyceridemia in type-2 diabetes: A meta-analysis. Diabetes Metab Syndr. 2020 Aug 31. doi.org/10.1016/j.dsx.2020.08.039 [PubMed] PMID: 32937280 [IMPACT FACTOR: 10]
  140. Dutta D, Bhattacharya S, Krishnamurthy A, Sharma LK, Sharma M. Efficacy and Safety of Novel Dipeptidyl-Peptidase-4 Inhibitor Evogliptin in the Management of Type 2 Diabetes Mellitus: A Meta-Analysis. Indian J Endocrinol Metab. 2020 Sep-Oct;24(5):434-445. [PubMed] PMID: 33489850 [IMPACT FACTOR: 1.7]
  141. Dutta D, Bhattacharya S, Sharma M et al. Effect of yoga on glycemia and lipid parameters in type-2 diabetes: a meta-analysis. J Diabetes Metab Disord (2021). https://doi.org/10.1007/s40200-021-00751-0
  142. Sharma LK, Sharma N, Kulshrestha B, Bansal R, Aggarwal A, Dutta D. Carbohydrate-rich Meals Have no Impact on Post-prandial Lipid Parameters in Indians with Subclinical and Overt Primary Hypothyroidism. European Endocrinology. 2020;16(2):161–6 [PubMed] PMID: 33117450
  143. Datta PK, Aravindan A, Nath S, Chowdhury SR, Dutta D. Nebulised magnesium sulphate as an adjuvant to the treatment of acute exacerbation of COPD: A systematic review and meta-analysis of randomised controlled trials with trial sequential analysis. Lung India. 2023 Jul-Aug;40(4):339-348. [PubMed] PMID: 37417087
  144. Dutta D, Sharma M, Dhall A, Aggarwal S, Khandelwal D. Glycaemic and weight-loss outcomes of graded doses of canagliflozin in type 2 diabetes — a real-world study. Clinical Diabetology. DOI: 10.5603/DK.2020.0044
  145. Dutta D, Sharma M, Sharma R. Short-term Hydroxychloroquine in COVID-19 Infection in People With or Without Metabolic Syndrome – Clearing Safety Issues and Good Clinical Practice. European Endocrinology. 2020;16(2):109–12 [PubMed] PMID: 33117441
  146. Kalra S, Joshi A, Dhingra A, Dutta D, Das S. Counselling for Testosterone Therapy in Mid Life Men. J Midlife Health. 2022 Apr-Jun;13(2):185-189. [PubMed] PMID: 36276624
  147. Singla R, Gupta G, Dutta D, Raizada N, Aggarwal S. Diabetes reversal: Update on current knowledge and proposal of prediction score parameters for diabetes remission. Diabetes Metab Syndr. 2022 Mar 10;16(4):102452. doi: 10.1016/j.dsx.2022.102452. Epub ahead of print. PMID: 35306265. [IMPACT FACTOR: 10]
  148. Krishnamurthy A, Bhattacharya S, Lathia T, Kantroo V, Kalra S, Dutta D. Anticancer Medications and Sodium Dysmetabolism. Eur Endocrinol. 2020 Oct;16(2):122-130. [PubMed] PMID: 33117443
  149. Dutta D, Khandelwal D, Kalra S. Injectable combination therapies for the management of diabetes: an Indian perspective. Expert Opin Drug Metab Toxicol. 2020 Mar;16(3):209-216.DOI: 10.1080/17425255.2020.1735351 [PubMed] PMID: 32098522 [IMPACT FACTOR: 3.49]
  150. Das S, Rastogi A, S. Harikumar K V, Dutta D, Sahay R, Kalra S, Ghosh S, Gupta SK, Pandit K, Jabbar P K, Damodaran S, Nagesh V S, Sheikh S, Madhu S V, Bantwal G. Diagnosis and management considerations in steroid-related hyperglycemia in COVID-19: A position statement from the endocrine society of India. Indian J Endocr Metab 2021;25:4-11 [PubMed] PMID: 34386386
  151. Priya G, Bajaj S, Kalra B, Coetzee A, Kalra S, Dutta D, et al. Clinical practice recommendations for the detection and management of hyperglycemia in pregnancy from South Asia, Africa and Mexico during COVID-19 pandemic, Journal of Family Medicine and Primary Care. 2021;10(12):4350-4363 doi: 10.4103/jfmpc.jfmpc_653_21
  152. Dutta D, Arora V, Dhingra A, Das AK, Fariduddin M, Shaikh K, et al. Quinary prevention in diabetes care: Need for multidisciplinary approach. Clinical Epidemiology and Global Health 2021, 100757 https://doi.org/10.1016/j.cegh.2021.100757
  153. Bhattacharya S, Kalra S, Dutta D, Khandelwal D, Singla R. The Interplay Between Pituitary Health and Diabetes Mellitus - The Need for 'Hypophyseo-Vigilance'. Eur Endocrinol. 2020 Apr;16(1):25-31. [PubMed] PMID: 32595766
  154. Dutta D, Ghosh S, Kalra S, Maisnam I, Sharma M. Is the Ketogenic Diet an Effective and Safe Approach to Type 2 Diabetes Management and Weight Loss? US Endocrinology. 2020;16(1):15–22 DOI: https://doi.org/10.17925/USE.2020.16.1.15
  155. Dutta D, Bhattacharya S, Surana V, Aggarwal S, Singla R, Khandelwal D, Sharma M, Response to the letter to the editor submitted by Jaiswal A et al. (2020) regarding ‘efficacy and safety of saroglitazar in managing hypertriglyceridemia in type-2 diabetes: A meta-analysis’ (Dutta et al.), Diabetes Metab Syndr. 2020;14 (6): 2093 https://doi.org/10.1016/j.dsx.2020.10.027. [PubMed][IMPACT FACTOR: 10]
  156. Dutta D, Sharma M, Shivaprasad K S, Kumar M. Vanishing pituitary macroprolactinoma and secondary hypothyroidism due to pituitary apoplexy. Thyroid Res Pract 2020;17:19-21
  157. Das AK, Kalra S, Krishnakumar B, Sharma K, John M, Nair T, Shaikh S, Khandelwal D, Priya G, Dutta D, et al. Cardiometabolic vigilance in COVID-19 and resource husbandry in resource-challenged times: Clinical practice- based expert opinion, Diabetes Metab Syndr. 2021;15(1):55-62 https://doi.org/10.1016/j.dsx.2020.11.014 [PubMed][IMPACT FACTOR: 10]
  158. Shaikh K, Shrestha C, Dutta D. Treatment options in people with COVID19: Selecting the best armamentarium against the novel virus. J Pak Med Assoc. 2020 May;70(Suppl 3)(5):S69-S73. [PubMed] PMID: 32515383
  159. Sharma M, Kumar M, Dutta D. Hydroxychloroquine in diabetes and dyslipidaemia: primum non nocere. Diabet Med. 2019. https://doi.org/10.1111/dme.14144 [PubMed] PMID: 31557353 [IMPACT FACTOR: 3.24]
  160. Dutta D, Ghosh S. Young-onset diabetes: An Indian perspective. Indian J Med Res 2019;149:441-2. [PubMed] PMID: 31411167 [IMPACT FACTOR: 2.2]
  161. Dutta D, Jaisani R, Khandelwal D, Ghosh S, Malhotra R, Kalra S. Role of metformin, Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors, Glucagon-Like Peptide-1 (GLP-1) receptor agonists, and orlistat based multidrug therapy in glycemic control, weight loss, and euglycemia in diabesity: A real-world experience. Indian J Endocr Metab 2019;23:460-7 [PubMed] PMID: 31741907
  162. Gupta L, Arora B, Khandelwal D, Lal PR, Kalra S, Bhattacharya S, Dutta D, Chittawar S, Paliwal A. Dietary Practices During Common Religious Fasts in People with Type 2 Diabetes Mellitus Among Different Religions in North India—A Questionnaire-based Study. US Endocrinology. 2020;16(1):36–40 DOI: https://doi.org/10.17925/USE.2020.16.1.36
  163. Anne B, Ghosh S, Ghosh I, Ray S, Chowdhury S, Dutta D. Prevalence of end-organ damage, beta cell reserve, and exocrine pancreas defect in fibrocalculous pancreatic diabetes: An Eastern India perspective. Indian J Endocr Metab 2019;23:438-45 [PubMed] PMID: 31741903
  164. Gupta L, Khandelwal D, Lal PR, Kalra S, Dutta D. Palaeolithic Diet in Diabesity and Endocrinopathies – A Vegan’s Perspective. European Endocrinology 2019;15(2):77–82 [PubMed] PMID: 31616497
  165. Sharma M, Kumar M, Dutta D. Vitamin D Supplementation, Insulin Resistance, and Cardiovascular Risk Factors: Who are Likely to Benefit the Most? Indian J Endocrinol Metab. 2019 Nov-Dec;23(6):650-652. [PubMed] PMID: 32042706
  166. Dutta D, Sharma M, Anand A, Garga UC, Bansal R, Sharma N. Increased trunk fat along with decreased peripheral fat as an important predictor of hypertriglyceridaemia & hypercholesterolaemia in Indians with HIV infection. Indian J Med Res. 2018 Oct;148(4):411-421. [PubMed] PMID: 30666003 [IMPACT FACTOR: 2.2]
  167. Arora B, Gupta L, Khandelwal D, Bhattacharya S, Kalra S, Chittawar S, Paliwal A, Lal PR, Dutta D. Knowledge, attitude, and practices of fasts in patients with type 2 diabetes among different religions in North India. Int J Diabetes Dev Ctries 2019; 40(1), 127-133
  168. Bhattacharya S, Kalra S, Dutta D, Khandelwal D, Singla R. The Interplay Between Pituitary Health and Diabetes Mellitus – The Need for ‘Hypophyseo-vigilance’ European Endocrinology. 2019;16(1):ePub ahead of Print [PubMed]
  169. Garg M, Khandelwal D, Aggarwal V, Raja KB, Kalra S, Agarwal B, Dutta D. Ultrasound elastography is a useful adjunct to conventional ultrasonography and needle aspiration in preoperative prediction of malignancy in thyroid nodules: A Northern India perspective. Indian J Endocr Metab 2018;22:589-96 [PubMed] PMID: 30294565
  170. S Kalra, Das AK, Fariduddin Md, Shaikh K, Shah P, Rehim AA, John M, Shaikh S, Orabi A, Saraswati MR, S Selim, Baruah MP, K K Gangopadhyay, Langi YA, Nair T, Dhanwal D, Thapa SD, Deshmukh V, D Dutta, et al. Glucodynamics and glucocracy in type 2 diabetes mellitus: clinical evidence and practice-based opinion on modern sulfonylurea use, from an international expert group (South Asia, Middle East & Africa) via modified Delphi method. Current Medical Research and Opinion 2020 DOI: 10.1080/03007995.2020.1864309
  171. Dutta D, Sharma M, Aggarwal S, Mohindra R, Bhattacharya S, Kalra S. Vitamin D, thyroid autoimmunity and cancer: An interplay of different factors. Indian J Endocr Metab 2019;23:507-13. [PubMed] PMID: 31803589
  172. Sharma N, Sharma LK, Anand A, Gadpayle AK, Gaurav K, Mukherjee S, Kulshreshtha B, Dutta D. Presence, patterns & predictors of hypocortisolism in patients with HIV infection in India. Indian J Med Res. 2018 Feb;147(2):142-150. [PubMed] PMID: 29806602 [IMPACT FACTOR: 2.2]
  173. Dutta D, Mukhopadhyay S. Hemoglobin A1c Targets for Glycemic Control With Pharmacologic Therapy. Ann Intern Med. 2018 Oct 2;169(7):511-512. doi: 10.7326/L18-0370. [PubMed] PMID: 30285192 [IMPACT FACTOR: 19.38]
  174. Dutta D, Garga UC, Gadpayle AK, Bansal R, Anand A, Gaurav K, Sharma LK, Sharma N. Occurrence & predictors of osteoporosis & impact of body composition alterations on bone mineral health in asymptomatic pre-menopausal women with HIV infection.Indian J Med Res. 2018 May;147(5):484-495 PMID: 30082573 [PubMed] [IMPACT FACTOR: 2.2]
  175. Sharma LK, Dutta D, Sharma N, Gadpayle AK. The increasing problem of subclinical and overt hypervitaminosis D in India: An institutional experience and review. Nutrition. 2017 Feb;34:76-81. PMID: 28063517 [PubMed] [IMPACT FACTOR: 3.05]
  176. Gupta L, Khandelwal D, Lal PR, Gupta Y, Kalra S, Dutta D. Factors Determining the Success of Therapeutic Lifestyle Interventions in Diabetes - Role of Partner and Family Support. Eur Endocrinol. 2019 Apr;15(1):18-24. PMID: 31244906 [PubMed]
  177. Dutta D, Shrestha D, Khandelwal D, Baruah M, Kalra S, Agarwal S, Bhattacharya S, Singla R, Surana V. A 2018 clinical practice pattern in the management of diabetes in India and Nepal: a three-city study. Int J Diabetes Dev Ctries 2018 https://doi.org/10.1007/s13410-018-0701-7
  178. Sharma M, Dhakad U, Wakhlu A, Bhadu D, Dutta D, Das SK. Lean mass and disease activity are the best predictors of bone mineral loss in the premenopausal women with rheumatoid arthritis. Indian J Endocr Metab 2018;22:236-43 [PubMed]
  179. Devru N, Dharmshaktu P, Kumar G, Dutta D, Kulshreshtha B. Phenotypic presentation of adolescents with overt primary hypothyroidism. J Pediatr Endocrinol Metab. 2018 Mar 28;31(4):415-420. PMID: 29584616 [PubMed] [IMPACT FACTOR: 1.23]
  180. Dutta D, Sharma LK, Sharma N, Gadpayle AK, Anand A, Gaurav K, Gupta A, Poondla Y, Kulshreshtha B. Occurrence, patterns & predictors of hypogonadism in patients with HIV infection in India. Indian J Med Res. 2017 Jun;145(6):804-814 PMID: 29067983 [PubMed] [IMPACT FACTOR: 2.2]
  181. Aggarwal A, Sharma M, Maisnam I, Ghosh S, Aggarwal S, Bhattacharya S, Dutta D. Drug-induced bone disorders: A systematic review. Indian J Rheumatol 2019;14:S44-51.
  182. Dutta D, Sharma M, Bansal R, Sharma N, Garga UC, Anand A, Gaurav K. Low skeletal mass is an important predictor of osteoporosis in HIV infected men in India. Endokrynol Pol. 2017 Oct 12. doi: 10.5603/EP.a2017.0053. PMID: 29022646 [PubMed] [IMPACT FACTOR: 0.99]
  183. Sharma LK, Sharma N, Gadpayle AK, Dutta D. Prevalence and predictors of hyperprolactinemia in subclinical hypothyroidism, Eur J Intern Med. 2016 Nov;35:106-110. PMID: 27473607 [PubMed] [IMPACT FACTOR: 2.91]
  184. Dutta D, Mukhopadhyay S. Intervening at prediabetes stage is critical to controlling the diabetes epidemic among Asian Indians. Indian J Med Res 2016;143:23-26 PMID: 27377494 [PubMed] [IMPACT FACTOR: 2.2]
  185. Unnikrishnan AG, Saboo BD, Majumdar A, Saraogi RK, Sundar S, Mahadevan S, Ramakrishnan A, Basu I, Dutta D, Bhattacharya AD, Bharathi P, Gawand K. Association Between Type 2 Diabetes and Hypogonadism in India: An Observational Study. Indian J Endocrinol Metab. 2024 Sep-Oct;28(5):473-479. doi: 10.4103/ijem.ijem_262_23. Epub 2024 Sep 4. PMID: 39676785; PMCID: PMC11642515.
  186. Dutta D, Mondal SA, Kumar M, Reza AHH, Singh P, Chakrabarti S, Mukhopadhyay S. Serum fetuin-A predicts glycemic outcomes in individuals with prediabetes: A prospective study from eastern India. Diabet Med. 2014 Dec;31(12):1594-9. PMID: 24975463 [PubMed] [IMPACT FACTOR: 3.24]
  187. Dutta D, Khandelwal D, Kalra S. Litchi-related hypoglycemia: A public health challenge, an endocrine opportunity. Indian J Endocr Metab 2019;23:380-1 [PubMed]
  188. Dutta D, Garg A, Khandelwal D, Kalra S, Mittal S, Chittawar S. Thyroid symptomatology across the spectrum of hypothyroidism and impact of levothyroxine supplementation in patients with severe primary hypothyroidism. Indian J Endocr Metab 2019;23:373-8 [PubMed]
  189. Bajaj S, Das AK, Kalra S, Sahay R, Saboo B, Das S, Shunmugavelu M, Jacob J, Priya G, Khandelwal D, Dutta D, Chawla M, Surana V, Tiwaskar M, Joshi A, Shrestha PK, Bhattarai J, Bhowmik B, Latt TS, Aye TT, Vijayakumar G, Baruah M, Jawad F, Unnikrishnan AG, Chowdhury S, Md. Pathan F, Somasundaram N, Sumanathilaka M, Raza A, Bahendeka SK, Coetzee A, Ruder S, Ramaiya K, Lamptey R, Bavuma C, Shaikh K, Uloko A, Chaudhary S, Abdela AA, Akanov Z, Rodr`ıguez-Saldana J, Faradji R, Tiago A, Reja A, Czupryniak L. BE-SMART (Basal Early Strategies to Maximize HbA1c Reduction with Oral Therapy): Expert Opinion. Diabetes Ther. 2019 Aug;10(4):1189-1204 PMID: 31102253 [PubMed] [IMPACT FACTOR: 2.31]
  190. Mondal SA, Dutta D, Kumar M, Singh P, Basu M, Selvan C, Mukhopadhyay S. Neck circumference to height ratio is a reliable predictor of liver stiffness and nonalcoholic fatty liver disease in prediabetes. Indian J Endocr Metab 2018;22:347-54. PMID: 30090726 [PubMed]
  191. Dutta D, Mukhopadhyay S. Novel diabetes subgroups. Lancet Diabetes Endocrinol. 2018 Jun;6(6):438. doi: 10.1016/S2213-8587(18)30129-3. PMID: 29803261 [PubMed] [IMPACT FACTOR: 32]
  192. Dutta D, Pandey RK, Gogoi R, Solanki N, Madan R, Mondal A, Dogra S, Thapa P. Occult phosphaturic mesenchymal tumor of femur cortex causing oncogenic osteomalacia: Diagnostic challenges and clinical outcomes. Endokrynol Pol. 2018 Feb 14. doi: 10.5603/EP.a2018.0016. PMID: 29442350 [PubMed]
  193. Deep Dutta, Pradeep Kumar Gupta, Meha Sharma, Nishikant Avinash Damble, Renu Madan, Shruti Dogra. 18F-fluorocholine-positron Emission Tomography/Computerised Tomography is Useful in Localising 99mTc-sestamethoxyisobutylisonitrile- negative Parathyroid Cyst Causing Normocalcemic Primary Hyperparathyroidism. European Endocrinology. 2018;14(1):56–58 PMID: 29922354 [PubMed]
  194. Chittawar S, Dutta D, Qureshi Z, Surana V, Khandare S, Dubey TN. Neutrophil-lymphocyte Ratio is a Novel Reliable Predictor of Nephropathy, Retinopathy, and Coronary Artery Disease in Indians with Type-2 Diabetes. Indian J Endocrinol Metab. 2017 Nov-Dec;21(6):864-870. PMID: 29285450 [PubMed]
  195. Chittawar S, Nagdeote A, Nair A, Kawre KK, Dutta D. Spectrum of clinical symptomatology and its resolution following levothyroxine supplementation in primary and subclinical hypothyroidism: An Indian perspective. Thyroid Res Pract 2018;15:29-33
  196. Nagendra L, Bhattacharya S, Kapoor N, Shaikh S, Das S, Mondal S, Khare J, Kota S, Mittal S, Mittal R, Sukumar S, Selvan C, Shenoy M, Shah S, Gadve S, Verma R, Sharma B, Dutta D, Mamidala VR, Shaikh A, Narayanan P, Jindal S, Ramakrishnan S, Kalra S. Colours of India: Uniting Endocrinologists in Fitness and Friendship. Indian J Endocrinol Metab. 2024 Sep-Oct;28(5):470-472. doi: 10.4103/ijem.ijem_64_24. Epub 2024 Oct 17. PMID: 39676779; PMCID: PMC11642507.
  197. Sharma N, Dutta D, Sharma L. Occurrence of hyperprolactinemia in children with subclinical hypothyroidism. J Clin Res Pediatr Endocrinol. 2017 May 22. doi: 10.4274/jcrpe.4536. PMID: 28529200 [PubMed] [IMPACT FACTOR: 1.57]
  198. Mukhopadhyay S, Mondal SA, Kumar M, Dutta D. Pro-inflammatory and anti-inflammatory attributes of fetuin-A: a novel hepatokine modulating cardiovascular and glycemic outcomes in metabolic syndrome. Endocr Pract. 2014 Nov 4:1-18.PMID: 25370330 [PubMed][IMPACT FACTOR: 2.49]
  199. Shivaprasad KS Kumar M, Dutta D, Sinha B, Mondal SA, Maisnam I, Mukhopadhyay S, Chowdhury S. Increased soluble TNF receptor-1 and glutathione peroxidase may predict carotid intima media thickness in females with Cushing’s syndrome. Endocr Pract. 2015 Mar 1;21(3):286-95. PMID: 25370329 [PubMed] [IMPACT FACTOR: 2.49]
  200. Sharma LK, Dutta D, Sharma N, Thakur B. Comparisons of metabolite profile from paired serum and ethylenediaminetetraacetic acid-plasma samples using dry chemistry technology: An emergency department perspective. J Lab Physicians. 2018 Jul-Sep;10(3):346-350. PMID: 30078974 [PubMed]
  201. Dutta D, Maisnam I, Selvan C, Ghosh S, Mukhopadhyay S, Chowdhury S. Role of parathyroid hormone estimation in needle washing of parathyroid aspiration biopsy in localizing 99mTc-sestamibinegative primary hyperparathyroidism: A series of seventeen patients. Clin Otolaryngol. 2014; 39: 174-197PMID: 24779646 [PubMed] [IMPACT FACTOR: 1.9]
  202. Dutta D, Mondal SA, Choudhuri S, Maisnam I, Reza AHH, Bhattacharya B, Chowdhury S, Mukhopadhyay S. Vitamin-D supplementation in prediabetes reduced progression to type 2 diabetes and was associated with decreased insulin resistance and systemic inflammation: An open label randomized prospective study from Eastern India. Diabetes Res Clinical Pract 2014 Mar;103(3):e18-23. PMID:24456991 [PubMed] [IMPACT FACTOR: 2.74]
  203. Chittawar S, Dutta D, Khandelwal D, Singla R. Neonatal endocrine labomas - Pitfalls and challenges in reporting neonatal Hormonal reports. Indian Pediatrics. 2017; 54: 757-762 PMID: 28984256 [PubMed] [IMPACT FACTOR: 1.04]
  204. Khandelwal D, Dutta D, Chittawar S, Kalra S. Sleep Disorders in Type 2 Diabetes. Indian J Endocrinol Metab. 2017 Sep-Oct;21(5):758-761. PMID: 28989888 [PubMed]
  205. Mukhopadhyay S, Dutta D. Is It Justified to Have a Lower BMI Cutoff for Metabolic Surgery for Asians with Type 2 Diabetes? Obes Surg. 2017 Jan 28. doi: 10.1007/s11695-017-2565-1. PMID: 28132127 [PubMed] [IMPACT FACTOR: 3.35]
  206. Kalra S, Dutta D. The diabetic knee. J Pak Med Assoc. 2019 Oct;69(10):1568-1569. PMID: 31622320 [PubMed]
  207. Selvan C, Dutta D, Thukral A, Nargis T, Kumar M, Mukhopadhyay S, et al. Neck height ratio is an important predictor of metabolic syndrome among Asian Indians. Indian J Endocr Metab 2016;20:831-837 PMID: 27867888 [PubMed]
  208. Kulshreshtha B, Arpita A, Rajesh PT, Sameek B, Dutta D, Neera S, Mohd M. Adolescent gynecomastia is associated with a high incidence of obesity, dysglycemia, and family background of diabetes mellitus. Indian J Endocr Metab 2017;21:160-4 PMID: 28217517 [PubMed]
  209. Dutta D, Dharmshaktu P, Aggarwal A, Gaurav K, Bansal R, Devru N, Garga UC, Kulshreshtha B. Severity and pattern of bone mineral loss in endocrine causes of osteoporosis as compared to age-related bone mineral loss. J Postgrad Med. 2016 May 31. doi: 10.4103/0022-3859.183170. PMID: 27241810 [PubMed] [IMPACT FACTOR: 1.10]
  210. Dutta D, Kalra S, Sharma M. Adenosine monophosphate-activated protein kinase-based classification of diabetes pharmacotherapy. J Postgrad Med. 2017 Apr-Jun;63(2):114-121. PMID: 27652986 [PubMed] [IMPACT FACTOR: 1.10]
  211. Khandelwal D, Dutta D, Singla R, Surana V, Aggarwal S, Gupta Y, Kalra S, Khadgawat R, Tandon N. Perceptions about training during endocrinology residency programs in India over the years: A cross-sectional study (PEER India Study). Indian J Endocr Metab 2017;21:271-6 PMID: 28459024 [PubMed]
  212. Surana V, Aggarwal S, Khandelwal D, Singla R, Bhattacharya S, Chittawar S, Kalra S, Dutta D. Society for Promotion of Education in Endocrinology and Diabetes Group. A 2016 clinical practice pattern in the management of primary hypothyroidism among doctors from different clinical specialties in New Delhi. Indian J Endocr Metab 2017;21:165-77 [PubMed]
  213. Meher D, Dutta D, Ghosh S, Mukhopadhyay P, Chowdhury S, Mukhopadhyay S. Effect of a mixed meal on plasma lipids, insulin resistance and systemic inflammation in non-obese Indian adults with normal glucose tolerance and treatment naive type-2 diabetes. Diabetes Res ClinPract 2014Apr;104(1):97-102.PMID: 24461623 [PubMed] [IMPACT FACTOR: 2.74]
  214. Biswas D, Dutta D, Maisnam I, Mukhopadhyay S, Chowdhury S. Occurrence of osteoporosis and factors determining bone mineral loss in Graves’ disease. Indian J Med Res2015;141: 322-329.PMID: 25963493 [PubMed] [IMPACT FACTOR: 2.2]
  215. Sharma N, Sharma L, Dutta D, Gadpayle A, Anand A, Gaurav K, Mukherjee S, Bansal R. Prevalence and Predictors of Thyroid Dysfunction in Patients with HIV Infection and Acquired Immunodeficiency Syndrome: An Indian Perspective. Journal of Thyroid Research, vol. 2015, Article ID 517173, 9 pages, 2015. doi:10.1155/2015/517173[PubMed]
  216. Roy A, Dutta D, Ghosh S, Mukhopadhyay P, Mukhopadhyay S, Chowdhury S. Efficacy and safety of low dose oral prednisolone as compared to pulse intravenous methylprednisolone in managing moderate severe Graves' orbitopathy: A randomized controlled trial. Indian J Endocrinol Metab 2015;19 (3): 351-358.PMID: 25932389 [PubMed]
  217. Dutta D, Maisnam I, Shrivastava A, Ghosh S, Mukhopadhyay P, Mukhopadhyay S, Chowdhury S. Serum vitamin-D predicts insulin resistance in individuals with prediabetes. Indian J Med Res 2013;138: 121-128. PMID:24521626 [PubMed] [IMPACT FACTOR: 2.06]
  218. Dutta D, Choudhuri S, Mondal SA, Mukherjee S, Chowdhury S. Urine albumin creatinine ratio predicts prediabetes progression to diabetes and reversal to normoglycemia: Role of associated insulin resistance, inflammatory cytokines and low vitamin-D. J Diabetes 2014 Jul;6(4):316-22. PMID: 24251376 [PubMed] [IMPACT FACTOR:2.91]
  219. D, Gupta L, Kalra S, Vishwakarma A, Lal PR, Dutta D. Diabetes Distress and Marriage in Type-1 Diabetes. Indian J Community Med. 2018 Oct-Dec;43(4):316-319. PMID: 30662188 [PubMed]
  220. Dutta D, Kumar M, Ghosh S, Mukhopadhyay S, Chowdhury S. Multiple pituitary hormone deficiency due to pituitary racemose neurocysticercosis. Lancet Diabetes Endocrinol. 2013 Oct;1(2):e13 PMID:24622323 [PubMed] [IMPACT FACTOR: 19.74]
  221. Gupta J, Khandelwal D, Gupta L, Dutta D, Mittal S, Khandelwal R, Chittawar S. Occurrence and Predictors of Diabetes Distress in Adult Patients with Type 2 Diabetes from North India. Indian J Endocrinol Metab. 2025 Mar-Apr;29(2):202-208. doi: 10.4103/ijem.ijem_170_24.
  222. Dutta D, Mukhopadhyay S. Comment on Anjana et al. Incidence of Diabetes and Prediabetes and Predictors of Progression Among Asian Indians: 10-Year Follow-up of the Chennai Urban Rural Epidemiology Study (CURES). Diabetes Care 2015;38:1441-1448. Diabetes Care. 2015 Sep;38 (9):e146. doi: 10.2337/dc15-0908 PMID: 26294782 [PubMed] [IMPACT FACTOR: 8.42]
  223. Dutta D, Choudhuri S, Mondal SA, Maisnam I, Reza AH, Ghosh S, Chowdhury S, Bhattacharya B, Mukhopadhyay S. Tumor necrosis factor alpha 238G/A (rs 361525) gene polymorphism predicts progression to type-2 diabetes in an Eastern Indian population with prediabetes. Diabetes Res Clin Pract. 2013 Mar; 99(3):e37-41. PMID: 23298660 [PubMed] [IMPACTFACTOR: 2.74]
  224. Dutta D, Mukhopadhyay S, Maisnam I, Ghosh S, Mukhopadhyay P, Chowdhury S. Neuroendocrine Carcinoma of the Thyroid Causing Adrenocorticotrophic Hormone-Dependent Cushing's Syndrome. Thyroid. 2013 Jan;23(1):120-3. PMID: 23140512 [PubMed] [IMPACT FACTOR: 3.54]
  225. Choudhuri S, Dutta D, Chowdhury IH, Mitra B, Sen A, Mandal LK, Mukhopadhyay S, Bhattacharya B. Association of hyperglycemia mediated increased advanced glycation and erythrocyte antioxidant enzyme activity in different stages of diabetic retinopathy. Diabetes Res Clin Pract. 2013Jun;100(3):376-84. PMID: 23602454 [PubMed] [IMPACT FACTOR: 2.74]
  226. Choudhuri S, Dutta D, Sen A, Chowdhury IH, Mitra B, Mondal LK, Saha A, Bhadhuri G, Bhattacharya B. Role of N–epsilon-carboxy methyl lysine, advanced glycation end products and reactive oxygen species for the development of non-proliferative and proliferative retinopathy in type2 diabetes mellitus. Molecular Vision 2013; 19:100-113 PMID: 23378723 [PubMed] [IMPACT FACTOR: 2.2]
  227. Gupta L, Khandelwal D, Kalra S, Gupta P, Dutta D, Aggarwal S. Ketogenic diet in endocrine disorders: Current perspectives. J Postgrad Med. 2017 Oct-Dec;63(4):242-251. PMID: 29022562 [PubMed] [IMPACT FACTOR: 1.10]
  228. Goyal D, Relia P, Sehra A, Khandelwal D, Dutta D, Jain D, et al. Prevalence of hypothyroidism and thyroid autoimmunity in polycystic ovarian syndrome patients: A North Indian study. Thyroid Res Pract 2019;16:55-9
  229. Dutta D, Kalra S, Sharma M. Reply to letter to editor regarding the article, "Adenosine monophosphate-activated protein kinase-based classification of diabetes pharmacotherapy". J Postgrad Med. 2017 Oct-Dec;63(4):276. PMID: 29022567 [PubMed] [IMPACT FACTOR: 1.10]
  230. Choudhuri S, Chowdhury IH, Das S, Dutta D, Saha A, Sarkar R, Mandal LK, Mukherjee S, Bhattacharya B. Role of NF-κB activation and VEGF gene polymorphisms in VEGF up regulation in non-proliferative and proliferative diabetic retinopathy. Mol Cell Biochem. 2015 Jul;405(1-2):265-79. doi: 10.1007/s11010-015-2417-z. PMID: 25956512 [PubMed] [IMPACT FACTOR: 2.388]
  231. Kumar P, Khandelwal D, Mittal S, Dutta D, Kalra S, Katiyar P, Aggarwal V. Knowledge, Awareness, Practices and Adherence to Treatment of Patients with Primary Hypothyroidism in Delhi. Indian J Endocrinol Metab. 2017 May-Jun;21(3):429-433. PMID: 28553600 [PubMed]
  232. Kalra S, Aggarwal S, Khandelwal D, Dutta D. Management of Glycemia in Acute Febrile Illness. Indian J Endocrinol Metab. 2017 May-Jun;21(3):460-463. PMID: 28553605 [PubMed]
  233. Bahety P, Agarwal G, Khandelwal D, Dutta D, Kalra S, Taparia P, Singhal V. Occurrence and predictors of depression and poor quality of life among patients with Type-2 diabetes: A Northern India perspective. Indian J Endocr Metab 2017;21:564-9 PMID: 28670541 [PubMed]
  234. Selvan C, Thukral A, Dutta D, Ghosh S, Chowdhury S. Impact of self-monitoring of blood glucose log reliability on long-term glycemic outcomes in children with type 1 diabetes. Indian J Endocr Metab 2017;21:382-6 PMID: 28553591 [PubMed]
  235. Dutta D, Ahuja A, Sharma L, Bhardwaj M, Kulshreshtha B. Macular amyloidosis complicating macroprolactinoma—a novel clinical association. Endokrynologia Polska 2015; 66(6):555-558 DOI:10.5603/EP.2015.0068PMID: 26662655 [PubMed] [IMPACT FACTOR: 0.99]
  236. Dutta D, Ahuja A, Selvan C. Immunoglobulin G4-related thyroid disorders — diagnostic challenges and clinical outcomes Endokrynologia Polska 2016; 67(5):528-532 DOI: 10.5603/EP.2016.0061 [PubMed] [IMPACT FACTOR: 0.99]
  237. Kulshreshtha B, Arpita A, Rajesh PT, Sameek B, Dutta D, Neera S, Mohd M. Adolescent gynecomastia is associated with a high incidence of obesity, dysglycemia, and family background of diabetes mellitus. Indian J Endocrinol Metab. 2017 Jan-Feb;21(1):160-164. PMID: 28217517 [PubMed]
  238. Gupta L, Khandelwal D, Dutta D, Kalra S, Lal PR, Gupta Y. The twin white herrings: Salt and sugar. Indian J Endocr Metab 2018;22:542-51. PMID: 30148105 [PubMed]
  239. Dutta D, Taneja A. Turner like dysmorphia as presenting feature of Type-II Mayer-Rokitansky-Kuster-Hauser syndrome. Indian J Med Res 2016;143(3):15-16 [PubMed] [IMPACT FACTOR: 2.2]
  240. Meher D, Dutta D, Misgar RA. Cutaneous manifestations of familial hypercholesterolaemia. Postgrad Med J. 2016 May;92(1087):304-5.PMID: 26739848 [PubMed] [IMPACT FACTOR: 1.549]
  241. Chaudhary S, Dutta D, Kumar M, Saha S, Mondal SA, Kumar A, Mukhopadhyay S. Vitamin-D supplementation reduces thyroid peroxidase antibody levels in patients with autoimmune thyroid disease: An open labeled randomized controlled trial. Indian J Endocr Metab 2016; 20:391-8PMID: 27186560 [PubMed]
  242. Kulshreshtha B, Sharma L, Sharma N, Singh Y, Aggarwal A, Dharmshaktu P, Yadav R, Dutta D. Octreotide and cinacalcet have limited role managing surgically incurable tumor induced osteomalacia. Acta Endo (Buc) 2015;11(4):517-523 doi: 10.4183/aeb.2015.517 [IMPACT FACTOR: 0.267]
  243. Meher D, Dutta D, Giri R, Kar M. Adrenal Leiomyoma Mimicking Adrenal Malignancy: Diagnostic Challenges and Review of Literature. J Endocrinol Metab. 2015;5(5):304-308
  244. Dutta D, Khandelwal D. Sodium glucose transporter 2 (SGLT2) inhibition, euglycemic ketosis and bone mineral loss: refining clinical practices. Indian J Endocr Metab2015;19:854-5.PMID: 26693443 [PubMed]
  245. Nagendra L, Dutta D. Challenges in Type 1 Diabetes Management in India Compared to Singapore. Indian J Endocrinol Metab. 2025 Mar-Apr;29(2):242-243. doi: 10.4103/ijem.ijem_207_24. PMID: 40416456 [PubMed]
  246. Kumar M, Mukhopadhyay S, Dutta D. Challenges and controversies in diagnosis and management of gonadotropin dependent precocious puberty: An Indian perspective. Indian J Endocrinol Metab 2015;19:228-35PMID: 25729684 [PubMed]
  247. Basu N, Dutta D, Maisnam I, Basu S, Ghosh S, Chowdhury S, Mukhopadhyay S. Efficacy and safety of percutanous ethanol ablation of simple vs. complex benign thyroid cysts: An eastern Indiaperspective. Indian J Endocrinol Metab 2014;18 (5): 662-668. PMID: 25285283 [PubMed]
  248. Mandal LK, Choudhuri S, Dutta D, Mitra BMD, Kundu S, Chowdhury IH, Sen A, Chatterjee M, Bhattacharya B. Oxidative Stress-Associated Neuroretinal Dysfunction and Nitrosative Stress in Diabetic Retinopathy. Can J Diabetes 2013; 37: 401-407. PMID: 24321721 [PubMed] [IMPACTFACTOR: 0.5]
  249. Choudhuri S, Mandal LK, Paine SK, Sen A, Dutta D, Chowdhury IH, Mukherjee A, Saha A, BhadhuriG, Bhattacharya B. Role of hyperglycemia mediated erythrocyte redox state alteration in the development of diabetic retinopathy. Retina. 2013 Jan;33(1):207-16.PMID: 22653543 [PubMed] [IMPACT FACTOR: 3.05]
  250. Choudhuri S, Mandal LK, Paine SK, Sen A, Dutta D, Chowdhury IH, Mukherjee A, Saha A, Bhadhuri G, Bhattacharya B. Reply: To PMID 22653543. Retina 2013 Jul-Aug;33(7):1481. PMID: 23656905 [PubMed][IMPACTFACTOR: 3.05]
  251. Dutta D, Selvan C, Mukhopadhyay S. Multiple Pituitary Hormone Deficiency, Empty Sella and Ectopic Neurohypophysis in Turner Syndrome. Indian Pediatr. 2015;52:803-4. PMID:26519720 [PubMed] [IMPACT FACTOR: 1.04]
  252. Maisnam I, Dutta D, Mukhopadhyay S, Chowdhury S. Lean mass is the strongest predictor of bone mineral content in type-2 diabetes and normal individuals: An eastern India perspective. J Diabetes Metab Disord.2014;13(1):90 doi:10.1186/s40200-014-0090-5 PMID: 25229052 [PubMed]
  253. Beatrice AM, Dutta D, Kumar M, Shivaprasad KS, Sinha A, Ray S, Chowdhury S. Testosterone levels and type 2 diabetes in men: current knowledge and clinical implications. Diabetes Metab Synd Obes. 2014 Oct 20;7:481-6. PMID: 25349479 [PubMed]
  254. Kalra S, Singla R, Rosha R, Dhawan M, Priya G Dutta D. Ketocrinology. US Endocrinology. 2018;14:59–61 DOI: https://doi.org/10.17925/USE.2018.14.2.59
  255. Dutta D, Mukhopadhyay S, Chowdhury S. Lack of Thelarche as the Presenting Feature of Bilateral Congenital Amastia. Indian J Pediatr. 2014;81(8):842-843 PMID: 24101164 [PubMed] [IMPACT FACTOR: 0.72]
  256. Dutta D, Sharma M, Mahajan V, Prem Chopra P. Sclerosing adenomatoid nodular transformation of spleen masquerading as carcinoma breast metastasis: importance of splenic biopsy in obviating splenectomy. Indian J Pathol Microbiol. 2016;59(2):223-226[PubMed][IMPACT FACTOR: 0.466]
  257. Kalra S, Khandelwal D, Singla R, Aggarwal S, Dutta D. Malaria and diabetes. J Pak Med Assoc. 2017 May;67(5):810-3. PMID: 28507380 [PubMed] [IMPACT FACTOR: 0.41]
  258. Sinha A, Dutta D, Shrivastav A, Mukhopadhyay P, Mukhopadhyay S, Chowdhury S. Association of different eGFR methods, calcium metabolism and anemia in diabetic chronic kidney disease: AnIndian perspective (Experience). Diabetologia Croatica2012;41(4):129-136
  259. Dharmshaktu P, Aggarwal A, Dutta D, Kulshreshtha B. Bilateral femoral head avascular necrosis with a very low dose of oral corticosteroid used for panhypopituitarism. BMJ Case Rep. 2016 Jan 13;2016. pii: bcr2015212803. doi: 10.1136/bcr-2015-212803.PMID: 26762348 [PubMed]
  260. Dutta D, Kumar M, Das RN, Datta S, Biswas D, Ghosh S, Mukhopadhyay S, Chowdhury S. Primary hyperparathyroidism masquerading as rickets: Diagnostic challenge and treatment outcomes. J Clin Res Pediatr Endocrinol 2013;5(4):266-269. PMID:24379038 [PubMed] [IMPACT FACTOR: 0.75]
  261. Dutta D, Selvan C, Kumar M, Datta S, Das RN, Ghosh S, Mukhopadhyay S, Chowdhury S. PTH in diagnosis of primary hyperparathyroidism due to intrathyroidal parathyroid cyst. Endocrinol Diabetes Metab Case Rep. 2013;2013:130019. doi: 10.1530/EDM-13-0019. Epub 2013Jul 1. PMID: 24616763 [PubMed]
  262. Dutta D, Biswas K, Arora R, Barman N, Bhushan D, Bhakhri BK. Profile and Height Outcomes of Children with Short Stature in North India: An Experience from a Tertiary Care Centre. Indian JPediatr.2014 Feb;81(2):205-6. PMID: 23616062 [PubMed] [IMPACT FACTOR:0.72]
  263. De BK, Dutta D, Pal SK, Gangopadhyay S, Baksi SD, Pani A. Role of garlic in hepatopulmonary syndrome: A randomized controlled trial. Can J Gastroenterol.2010 Mar;24(3):183-8 PMID: 20352147 [PubMed] [IMPACT FACTOR: 2.54]
  264. Biswas A, Banerjee A, Chandra PK, Datta S, Panigrahi R, Dutta D, De BK, Pal M, Guha SK, Chakrabarti S, Chakravarty R. Variations in the functional domain of basal core promoter of hepatitis B virus among Eastern Indian patients with prevalence of genotypes A, C, and D among the same ethnic population. J Med Virol. 2011 Feb;83(2):253-60 PMID: 21181919 [PubMed] [IMPACTFACTOR: 2.82]
  265. De BK, Gangopadhyay S, Dutta D, Baksi SD, Pani A, Ghosh P. Pentoxifylline versus prednisolone for severe alcoholic hepatitis: A randomized controlled trial. World J Gastroenterology 2009 April7; 15(13): 1613-1619 PMID: 19340904 [PubMed] [IMPACT FACTOR:2.594]
  266. De BK, Dutta D, Som R, Biswas PK, Pal SK, Biswas A. Hemodynamic effects of propranolol with spironolactone in patients with variceal bleeds: A randomized controlled trial. World J Gastroenterology 2008 March 28; 14(12): 1908-1913 PMID: 18350631 [PubMed] [IMPACT FACTOR: 2.594]
  267. Dutta D, Shivaprasad KS, Das RN, Ghosh S, Chowdhury S. Primitive neuroectodermal tumor of adrenal: Clinical presentation and outcomes. J Can Res Ther. 2013;9: 709-11PMID:24518722[PubMed] [IMPACT FACTOR: 0.89]
  268. Bhattacharya R, Pani A, Dutta D, Gangopadhyay S, Baksi SD, Sarkar RN. Randomized controlled trial evaluating the role of tirofiban in high risk non-ST elevation acute coronary syndromes: An eastern India perspective Singapore Medical Journal 2010; 51(7): 558-564 [IMPACT FACTOR:0.73]
  269. Ray R, Dutta D, Basu P, De BK. Quality of life assessment of patients with chronic liver disease in eastern India using a Bengali translation Chronic Liver Disease Questionnaire Indian Journal of Gastroenterology 2010 Sep; 29(5):187-95. PMID: 20740340 [PubMed] [IMPACT FACTOR: 0.7]
  270. Dutta D, Kumar M, Mukhopadhyay S, Chowdhury S. Graves' Orbitopathy Precipitated by Iatrogenic Hypothyroidism Secondary to Carbimazole for Graves' Disease. Indian J Pediatr. 2014 Nov;81(11):1244-5. PMID: 24777624 [PubMed] [IMPACT FACTOR: 0.72]
  271. Dutta D, Roy A, Mukhopadhyay S, Chowdhury S. Labial Neurofibroma as the Presenting Feature of Genital and Orbitotemporal Neurofibromatosis. Indian J Pediatr. 2014;81(8):829-830. PMID:24374492 [PubMed] [IMPACT FACTOR: 0.72]
  272. Mani S, Dutta D, De BK. Primitive Neuroectodermal Tumor of the Liver: A Case Report. Japanese Journal of Clinical Oncology2010 Mar;40(3):258-62. PMID: 19995788 [PubMed] [IMPACT FACTOR: 1.9]
  273. Dutta D, Khadgawat R. Endocrine disruptors: Can it be the missing link explaining the diabetes epidemic in India? Journal of Social Health and Diabetes.2014; 3(1):16-21. DOI: 10.4103/2321-0656.140878
  274. Dutta D, Kalra S. Sodium glucose transporter 2 (SGLT2) inhibitors: Current status in clinical practice. J Pak Med Assoc. 2014 Oct;64(10):1203-6. PMID: 25823168 [IMPACT FACTOR: 0.41]
  275. Choudhary N, Aggarwal I, Dutta D, Ghosh A, Ghosh S, Chatterjee G, Chowdhury S. Acquired perforating dermatosis and Addison’s disease due to disseminated histoplasmosis: Presentation and clinical outcomes.Dermato-Endocrinology 2013;5 (1): 1–4 PMID: 24194970 [PubMed]
  276. Dutta D, Jain R, Kumar M, Thukral A, Chowdhury S, Mukhopadhyay S. Solitary median maxillarycentral incisor, a clinical predictor of hypoplastic anterior pituitary, ectopic neurohypophysis and growth hormone deficiency. J Pediatr Endocrinol Metab2013;26(9-10):809-10.PMID: 23729612 [PubMed] [IMPACT FACTOR: 1.23]
  277. Dutta D, Kumar M, Sen A, Chowdhury JR, Mukhopadhyay M, Mukhopadhyay S, Chowdhury S. Skull metastasis as the presenting feature of mixed medullary and follicular thyroid carcinoma. Acta Endocrinologica (Buc.) 2014;10 (2): 299-306 doi: 10.4183/aeb.2014.299 [IMPACT FACTOR: 0.267]
  278. Dutta D, Shivaprasad KS, Kumar M, Biswas D, Ghosh S, Mukhopadhyay P, Mukhopadhyay S, Chowdhury S. Conservative management of severe bilateral emphysematous pyelonephritis: Case series and review of literature. Indian J Endocr Metab 2013;17:S329-32.PMID:24251204 [PubMed]
  279. Dutta D, K Biswas, M Sharma, R Maskey, M Baruah, M Amin. Managing diabetes during Navratris with special focus on Durga pujas. Journal of Social Health & Diabetes 2015;3(3):84-88
  280. Dutta D, Shivaprasad KS, Das RN, Ghosh S, Chatterjee U, Chowdhury S, Dasgupta R. Ovotesticular disorder of sexual development due to 47,XYY/46,XY/45,X mixed gonadal dysgenesis in a phenotypic male presenting as cyclical haematuria: clinical presentation and assessment of long-term outcomes. Andrologia 2014 Mar;46(2):191-3. PMID:23163819 [PubMed] [IMPACT FACTOR: 1.8]
  281. Dutta D, Maisnam I, Ghosh S, Mukhopadhyay S, Chowdhury S. Syndrome of extreme insulin resistance (Rabson Mendenhall phenotype) with atrial septal defect: Clinical presentation and treatment outcomes. J Clin Res Pediatr Endocrinol 2013;5(1):58-61. PMID: 23367497[PubMed] [IMPACT FACTOR: 0.75]
  282. Dutta D, Kumar M, Thukral A, Biswas D, Jain R, Ghosh S, Mukhopadhyay S, ChowdhuryS. Medical Management of Thyroid Ectopia: Report of Three Cases. J Clin Res Pediatr Endocrinol 2013 Sep 10;5(3):212-5. doi: 10.4274/Jcrpe.1103.PMID: 24072094 [PubMed- Indexed for Medline] [IMPACT FACTOR: 0.75]
  283. Dutta D, Roy A, Ghosh S, Mukhopadhyay P, Dasgupta R, Mukhopadhyay S, Chowdhury S. Rathke’s cyst with ectopic neurohypophysis presenting as severe short stature with delayed puberty. Indian J Endocr Metab 2012;16:S288-90 PMID: 23565402[PubMed]
  284. Dutta D, Chittawar S, Khandelwal D, Aggarwal S. Vitamin-D and thyroid: Permissive effect of vitamin-D on thyroid autoimmunity and cancer. J Indian Med Assoc 2018 May; 116(5): 324-329
  285. Khandelwal D, Dutta D, Chittawar S. Patient’s knowledge and perception about hypothyroidism. J Indian Med Assoc 2018 April; 116(4): 229-234
  286. Dutta D, Das RN, Ghosh S, Mukhopadhyay S, Chowdhury S. Idiopathic hypoparathyroidism and systemic sclerosis: An association likely missed. Indian J Endocr Metab 2012;16: S396-8 PMID:23565441 [PubMed]
  287. Dutta D, Shivaprasad KS, Ghosh S, Mukhopadhyay S, Chowdhury S. Adrenal myelolipoma with keratoconus: A novel clinical association. Indian J Endocr Metab 2012;16:S364-6. PMID: 23565430[PubMed]
  288. Dutta D, Maisnam I, Ghosh S, Mukhopadhyay P, Mukhopadhyay S, Chowdhury S. Panhypopituitarism with empty sella a sequel of pituitary hyperplasia due to chronic primary hypothyroidism. Indian J Endocr Metab 2012;16:S282-4PMID: 23565400 [PubMed]
  289. Dutta D, Maisnam I, Ghosh S, Dasgupta R, Mukhopadhyay S, Chowdhury S. Tetany due to hypoparathyroidism as the initial manifestation of autoimmune polyendocrine syndrome type-2: Acase report. Indian J Endocr Metab 2012;16:S495-7 PMID: 23565477 [PubMed]
  290. Dutta D. Neonatal Endocrine Labomas: Few Concerns: Authors Reply. Indian Pediatr. 2018 Jan 15;55(1):81. PMID: 29396954 [PubMed]
  291. Dutta D, Chowdhury S. Endocrine Labomas. Indian J Endocr Metab 2012;16:S275-8 PMID:23565398 [PubMed]
  292. Dutta D, Ghosh S, Mukhopadhyay S, Chowdhury S. Rapid reduction with cystic transformation of invasive giant prolactinoma following short-term low dose cabergoline. Indian J Endocr Metab.2012; 16 (6): 1048-51 PMID: 23226667 [PubMed]
  293. Dutta D, Jain R, Maisnam I, Ghosh S, Mukhopadhyay S, Chowdhury S. Isolated Cushing’s syndrome in early infancy due to left adrenal adenoma: An unusual aetiology. J Clin Res Pediatr Endocrinol 2012;4(3):164-168 PMID: 22985617 [PubMed] [IMPACT FACTOR: 0.75]
  294. Dutta D, Shivaprasad KS, Ghosh S, Mukhopadhyay S, Chowdhury S. Iatrogenic Cushing’s syndrome due to inhaled steroids. J Clin Res Pediatr Endocrinol 2012;4(3):157-159 PMID: 22985615 [PubMed] [IMPACT FACTOR: 0.75]
  295. Dutta D, Ghosh S. Vitamin-D and thyroid: Autoimmunity and cancer. Thyroid Research & Practice2013;10 (1): 1-3
  296. Dutta D, Ghosh S, Pandit K, Mukhopadhyay P, Chowdhury S. Leptin and cancer: pathogenesis and modulation. Indian J Endocr Metab 2012;16:596-600PMID: 23565495 [PubMed]
  297. Dutta D, Maisnam I, Shrivastava A, Sinha A, Ghosh S, Mukhopadhyay P, Mukhopadhyay S, Chowdhury S. Does serum vitamin-D predict insulin resistance in individuals with prediabetes? Authors’ Response. Indian J Med Res 2014; 139: 956-957 [IMPACT FACTOR: 2.06]
  298. Dutta D, Maisnam I, Shrivastava A, Sinha A, Ghosh S, Mukhopadhyay P, Mukhopadhyay S, Chowdhury S. Insulin resistance & vitamin-D levels in prediabetics. Authors’ response. Indian J Med Res 2014; 139: 958-960 [IMPACT FACTOR: 2.06]
  299. Kalra S, Khandelwal D, Singla R, Aggarwal S, Dutta D. Response to comment on Sanjay Kalra et al (J Pak Med Assoc. 2017; 5: 810-813) - Malaria, red blood cells turnover and glycated hemoglobin: Pitfalls and challenges. J Pak Med Assoc. 2017 Nov;67(11):1786. PMID: 29171590 [PubMed]
  300. Dutta D. The making of an endocrinologist in India: Life andtimes at Institute of Post Graduate Medical Education and Research Calcutta.Indian J EndocrMetab 2015;19:676-9. [PubMed]
  301. Dutta D, Kumar M, Jain R, Thukral A, Ghosh S, Mukhopadhyay S, Chowdhury S. Pituitary hyperplasia and Van WykGrumbach syndrome: A consequence of chronic untreated congenital hypothyroidism. Journal of the ASEAN Federation of Endocrine Societies 2013;28 (1): 88-89
  302. Dutta D, Jain R, Roy A, Ghosh S, Mukhopadhyay S, Chowdhury S. Spectrum of thyroid hormone resistance. Thyroid Research and Practice, May-Aug 2012;9(2): 64-67
  303. Dutta D, Maisnam I, Ghosh S, Mukhopadhyay P, Mukhopadhyay S, Chowdhury S. Marcus-Gunn Jaw Winking Syndrome and Gustatory Sweating in Long Standing Poorly Controlled Diabetes: A Case Report. International Journal of Clinical Medicine, 2012, 3, 40-42
  304. Dutta D, Kumar M, Jain R, Thukral A, Biswas D, Ghosh S, Mukhopadhyay S, Chowdhury S. Metastatic adenocarcinoma arising from fibrocalcific pancreatic diabetes. Journal of the ASEAN Federation of Endocrine Societies 2013;28 (2): 165-66
  305. Dutta D, Mukhopadhyay S. Tattooing as a therapy for goiter. Thyroid Res Pract2015;12:83DOI: 10.4103/0973-0354.153340
  306. Dutta D. The making of an endocrinologist in India: Life and times at Institute of Post Graduate Medical Education and Research Calcutta. Indian J Endocrinol Metab. 2015;19:676-9. PMID: 26425482 [PubMed]
  307. Selvan C, Dutta D, Maisnam I, Thukral A, Chakraborthy PP, Roy A, et al. Thyroid associated orbitopathy with ocular myasthenia in primary hypothyroidism: Keep those eyes open. Indian J Endocrinol Metab 2013;17:S657-9 [PubMed]
  308. Sanyal T, Dutta D, Shivaprasad KS, Ghosh S, Mukhopadhyay S, Chowdhury S. Gynaecomastia as the initial presentation of thyrotoxicosis. Indian J Endocrinol Metab 2012;16:S352-3 PMID: 23565425[PubMed]
  309. Srivastav A, Maisnam I, Dutta D, Ghosh S, Mukhopadhyay S, Chowdhury S. Cretinism revisited. Indian J Endocrinol Metab 2012;16:S236-7PMID: 23565419 [PubMed]
  310. Chakraborty PP, Dutta D, Biswas K, Sanyal T, Ghosh S, Mukhopadhyay S, Chowdhury S. Pancreatic carcinoma in fibrocalcific pancreatic diabetes: An eastern India perspective. Indian J Endocrinol Metab 2012;16:S486-8 PMID: 23565475 [PubMed]
  311. Maisnam I, Dutta D, Jain R, Ghosh S, Mukhopadhyay S, Chowdhury S. Plurihormone secreting pituitary macroadenoma masquerading as thyrotoxicosis: Clinical presentation and diagnostic challenges. Indian J Endocrinol Metab 2012;16:S315-7 PMID: 23565411 [PubMed]
  312. Shivaprasad KS, Dutta D, Jain R, Ghosh S, Mukhopadhyay S, Chowdhury S. Familial glucocorticoid deficiency presenting with generalized hyperpigmentation in adolescence: Report of three siblings. Indian J Endocrinol Metab 2012;16:S382-4 PMID: 23565437 [PubMed]
  313. Beatrice AM, Dutta D. A walk to remember: Endocrine Society of India Torrent Young Scholar Award East Zonal round 2015. Indian J Endocrinol Metab. 2015;19(6):848-9. PMID: 26693440 [PubMed]
  314. Jain R, Dutta D, Shivaprasad KS, Maisnam I, Ghosh S, Mukhopadhyay S, Chowdhury S. Acromegaly presenting as hirsuitism: Uncommon sinister aetiology of a common clinical sign. Indian J Endocrinol Metab 2012;16:S297-9 PMID: 23565405 [PubMed]
  315. Selvan C, Dutta D, Ghosh S, Mukhopadhyay S, Chowdhury S. Growth hormone deficiency, secondary hypothyroidism, and empty sella following treatment of childhood macroprolactinoma. Indian J Endocrinol Metab 2013;17:S132-4. PMID:24251133 [PubMed]
  316. Kumar M, Dutta D, Shivaprasad KS, Jain R, Sen A, Biswas D, Mukhopadhyay M, Ghosh S, Mukhopadhyay S, Chowdhury S. Diabetes insipidus as a presenting manifestation of Rathke’s cleft cyst. Indian J Endocrinol Metab 2013;17:S127-9. PMID:24251131 [PubMed]
  317. Shivaprasad KS, Dutta D, Jain R, Kumar M, Maisnam I, Biswas D, Ghosh S, Mukhopadhyay S, Chowdhury S. Huge bilateral ovarian cysts in adulthood as the presenting feature of Van Wyk Grumbach syndrome due to chronic uncontrolled juvenile hypothyroidism. Indian J Endocrinol Metab2013;17:S164-6. PMID:24251131 [PubMed]
  318. Thukral A, Chitra S, Chakraborty PP, Roy A, Goswami S, Bhattacharya R, Dutta D, Maisnam I, Ghosh S, Mukherjee S, Chowdhury S. De morseir syndrome presenting as ambiguous genetalia. Indian J Endocrinol Metab 2012;16: S509-11 PMID: 23565482 [PubMed]
  319. Biswas K, Sharma M, Dutta D, Barman N. Ocular myasthenia with thyroid associated ophthalmopathy in subclinical Graves' disease: Diagnostic challenge and treatment outcomes. Thyroid Res Pract 2014;11:73-5.DOI: 10.4103/0973-0354.129734
  320. Khandelwal D, Dutta D, Gupta J. A case of early morning abnormal behavior and refractory epilepsy. J Indian Med Asso. 116(10): 82-83
  321. P Dutta P, Gupta G, Singla R, Kantroo V, Bandhopadhyay D, Dutta D, Bhattacharya S. Artificial sweeteners: Clinical perspective. J Indian Med Asso. 116(10): 67-71
  322. Surana V, Singla R, Aggarwal S, Khandelwal D, Bhattacharya S, Kalra S, Dutta D. Short stature- clinical approach to diagnosis: A 2018 perspective. J Indian Med Asso. 116(10): 56-62
  323. Gupta P, Agarwal V, Khandelwal D, Garg M, Dutta D, Garg A. Nesidioblastosis–Nonlocalized Hyperinsulinemic Hypoglycemia: A Diagnosis Likely Missed. World J Endoc Surg 2019; 11 (3):91-93

Copyright @ 2026 Dr Deep Dutta all right reserved.

loader